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ABSTRACT
BIOLOGICAL ACTIVITY AND DYNAMIC STRUCTURE IN ARTIFICIAL
PROTEIN HYDROGELS
MAY 2002
SCOTT B. KENNEDY, B.S., UNIVERSITY OF ILLINOIS URBANA-
CHAMPAIGN
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Thomas P. Russell and Professor David A. Tirrell
Techniques of genetic engineering have recently allowed for the synthesis of
artificial, multidomain proteins. One exciting example of such a system is the recently
published work of Petka et al describing an artificial protein comprised of three domains.
One domain is an artificial sequence of amino acids designed to be highly charged, water
soluble, and absent of secondary or tertiary structure. Flanking this domain are two
domains designed after the amino acid sequential motif of leucine zippers. Leucine
zippers are a naturally occurring class of proteins or protein domains that form a-helical
structures and reversibly self-associate in aqueous solution with changes in pH and
temperature. This artificial "triblock" protein design behaves as a physical gel in
concentrated solutions near physiological conditions. In keeping with the exciting
promise for future development of this system, three projects develop.
First, incorporation of a site susceptible to hydrolysis by thrombin demonstrates a
biologically active hydrogel. As site specific activity was not present in Petka's original
vii
design, new protein designs incorporate an enzyme cleavable site at both ends of the
water-soluble coil domain. Gels prepared from the new protein irreversibly liquefy upon
exposure to thrombin, and a complete kinetic analysis indicates successful incorporation
of site-specific biological activity.
Second, ultracentrifugation and small angle x-ray scattering (SAXS) were used to
elucidate the gel structure. Dilute solution ultracentrifugation indicates tetrameric
association of the leucine zipper domain. SAXS profiles from gel samples are also
consistent with a large population of tetrameric aggregates. Together these results
strengthen the hypothesis that leucine zipper associations act as physical crosslinks.
Finally, the evidence for a well-defined and controllable gel structure provided by
SAXS led to a study of gel dynamics by diffusing wave spectroscopy (DWS). Coupled
with fluorescence resonance energy transfer experiments, DWS results indicate that
macroscopic physical properties correlate with molecular dynamics. This result opens
the door to a wide range of potential and promising applications for precision-engineered
physical protein hydrogels.
viii
TABLE OF CONTENTS
Page
ACKNOWLEDGMENTS v
ABSTRACT
vii
LIST OF TABLES
xii
LIST OF FIGURES xiii
LIST OF ABBREVIATIONS xvii
CHAPTER
1
.
HYDROGELS , PROTEIN HYDROGELS
,
AND GENETIC ENGINEERING 1
A. Motivation 1
B. Foundational Protein Design 2
C. Goals 9
D. References 10
2. SYNTHESIS OF GENETICALLY ENGINEERED PROTEINS
WITH SITE-SPECIFIC BIOLOGICAL ACTIVITY
t
13
A. Introduction and Objectives 13
B. Experimental Methods 15
1. Design Strategy 15
2. Protein Expression and Purification 26
3. Protein Characterization 28
a. Verification of Protein Synthesis 28
b. Verification of Site Selective Hydrolysis by Thrombin 29
C. Results and Discussion 38
D. Conclusions 51
E. References 52
3. KINETIC ANALYSIS OF THROMB IN REACTING ON
GENETICALLY ENGINEERED PROTEINS 54
ix
A. Introduction and Objectives 54
B. Experimental Methods 56
1. Protein Biosynthesis and Purification 56
2. Determination of Reaction Velocity 58
3. Determination of Michaelis-Menten Kinetic Parameters 61
C. Results and Discussion 61
D. Conclusions 74
E. References 76
4. A STATIC PICTURE OF GEL STRUCTURE 77
A. Introduction and Objectives 77
B. Experimental Methods 80
1. Protein Biosynthesis and Purification 80
2. Dilute Solution Circular Dichroism 82
3. Dilute Solution Analytical Ultracentrifugation 83
4. Small Angle X-ray Scattering 85
5. Computer Model for Theoretical Scattering 86
C. Results and Discussion 87
D. Conclusions 110
E. References Ill
5. FUTURE DIRECTIONS: CONTROLLED DYNAMIC
STRUCTURE AND UNIQUELY ACTIVE HYDROGELS 113
A. Introduction and Objectives 113
B. Experimental Methods 114
1. Labeling Protein with Fluorescent Probes 114
2. Fluorescence Resonance Energy Transfer 115
3. Fluorescence Recovery after Photobleaching 115
4. Diffusing Wave Spectroscopy 116
C. Results and Discussion 117
D. Conclusions L23
E. References 125
APPENDICES
A. INTERPRETING WEIGHT- AND Z- AVERAGE MOLECULAR •
WEIGHTS FROM ULTRACENTRIFUGATION 126
x
B. LEUCINE ZIPPER ORIENTATION DETERMINED BY
FLUORESCENCE RESONANCE ENERGY TRANSFER 128
BIBLIOGRAPHY 131
xi
LIST OF TABLES
Table page
2.1 Amino acid composition analysis of C-cys 40
2.2 Amino acid composition analysis of ATC-cys 40
2.3 Amino acid composition analysis of CTA-cys 41
2.4 Amino acid composition analysis of ATCTA-trp 41
2.5 Amino acid composition analysis of ATCTA-cys 42
2.6 Amino acid composition analysis of CTATC-cys 42
2.7 Summary of MALDI-TOF mass spectra 43
2.8 Summary of MALDI-TOF mass spectra after exposure to thrombin 48
3.1 Experimentally measured kinetic parameters for thrombin acting
on genetically engineered multidomain proteins 71
4.1 Definitions for analytical ultracentrifugation fitting parameters 84
xii
LIST OF FIGURES
Figure Page
1.1 Helical wheel representation of a 72 helix 5
1.2 Schematic illustration of a) parallel and b) antiparallel dimer coiled-coils 5
1.3 Schematic illustration of a) parallel and b) antiparallel trimer helical bundles ... 6
1.4 Schematic illustration of a) parallel and b) antiparallel tetramer helical bundles
. .6
1 .5 Schematic illustration of ACA protein design 7
1.6 Schematic illustration of hypothetical gel structure 8
2.1 Schematic illustration of ATCTA and the proposed response to thrombin 14
2.2 Schematic illustration of a hypothetical ATCTA gel structure
and the proposed response to thrombin 15
2.3 Sequence of coding (5'-3') and noncoding (3'-5') DNA for T incorporated
into the Nhel and Spel restriction sites of cloning vector pWAP-L2.
Important restriction sites are underlined 16
2.4 Schematic illustration of pUC18-L2T and pUC18-L2C plasmid construction . . 30
2.5 Schematic illustration of L2T, L2C, LI A, and L2A insert construction 31
2.6 Schematic illustration of A- and C- vector construction 32
2.7 Schematic illustration of pUC18-L2ATC plasmid construction 33
2.8 Schematic illustration of pUC18-L2CTA plasmid construction 34
2.9 Schematic illustration of pUC18-LlATCTA and pUC18-L2ATCTA
plasmid construction 35
2.10 Schematic illustration of pUC18-L2CTATC plasmid construction 36
2.11 Schematic illustration of gene transfer from pUC18 cloning plasmid to the
pQE9 expression vector 37
xiii
2.12 SDS-PAGE demonstrating controlled expression at 0, 45, and 240
minutes after induction (left to right) for proteins: C-cys (lanes 2-4),
ATC-cys (5-7), ATCTA-trp (8-10), CTA-cys (11-13), ATCTA-cys
(15-17), and CTATC-cys (18-20). Lanes 1 and 14 contain molecular
weight markers of 68, 43, 18.4, 14.3, and 6.2 kDa 38
2. 13 Targeted amino acid sequence for a) C-cys, b) ATC-cys, c) CTA-cys,
d) ATCTA-trp, e) ATCTA-cys, f) CTATC-cys. The thrombin cleava'ble
domain is bold, the random coil domain is italic 39
2. 14 MALDI-TOF mass spectrum of C-cys 44
2.15 MALDI-TOF mass spectrum of ATC-cys 44
2.16 MALDI-TOF mass spectrum of CTA-cys 45
2.17 MALDI-TOF mass spectrum of ATCTA-trp 45
2.18 MALDI-TOF mass spectrum of ATCTA-cys 46
2.19 MALDI-TOF mass spectrum of CTATC-cys 46
2.20 Representative HPLC chromatogram of thrombin-digested proteins.
Random coil domain elutes at -20 minutes, all proteins containing
a helical domain elute at -30 minutes 47
2.21 MALDI-TOF mass spectrum of thrombin digested ATC-cys and the
expected fragment masses 49
2.22 MALDI-TOF mass spectrum of thrombin digested CTA-cys and the
expected fragment masses 49
2.23 MALDI-TOF mass spectrum of thrombin digested ATCTA-trp and the
expected fragment masses 50
2.24 MALDI-TOF mass spectrum of thrombin digested ATCTA-cys and the
expected fragment masses 50
2.25 MALDI-TOF mass spectrum of thrombin digested CTATC-cys and the
expected fragment masses 51
3.1 Representative plot for the production of random coil domain. Data taken
from enzyme hydrolysis of ATC-cys (43 uM) 62
3.2 Michaelis-Menten analysis of ATC-cys (•) and CTA-cys () 64
xiv
3.3 Michaelis-Menten analysis of CTATC-cys plotted according
to protein concentration (•) and reactive site concentration () 65
3.4 Empirical relationship between concentration of coil domains and
helical domains as ATCTA hydrolyses via enzymatic activtity 69
3.5 Evolution of random coil domains as enzyme cleaves ATCTA systems 70
3.6 Evolution of helical domains as enzyme cleaves ATCTA systems 71
3.7 Michaelis-Menten analysis for the newly developed series of
proteins, ATC-cys (•), CTA-cys (), ATCTA (trp & cys) (A),
and CTATC-cys () 72
3.8 Comparison of reaction rates for solutions (.) and gels, as determined
by the fluid model () and static model () analyses 74
4. 1 Theoretical dimensions of possible helical structures 79
4.2 Thermal melting transitions for ACA-trp (5 uM), measured by CD
with increasing (•) and decreasing () temperature, and ACA-cys (5 uM)
reported by Petka etal.(+) 88
4.3 Summary of analytical ultracentrifugation for A-trp. Both RI (•) and
UV () detection techniques utilized. The highest concentration data ()
fit poorly to the model used 90
4.4 Summary of analytical ultracentrifugation for A-trp. Two fitting
schemes, floating Ki,4 (•) and K],2 (), are represented along with
the expected molecular weight of A-trp ( ) 92
4.5 Hypothetical progression of ACA-trp structures 94
4.6 Analytical ultracentrifuge data (UV) for 1 mg/mL A-trp (bottom plot)
and residuals from a fixed equilibrium fit (top plot). Fit indicates a
weight average molecular weight of 39576 Da 95
4.7 SAXS from a 7% (w/v) ACA-trp gel (pH 7.6, 25° C, after annealing),
representative plot for Guinier analyses of gels 97
4.8 Summary of Guinier analyses of 7% (w/v) ACA-trp before () and
after (•) a two minute anneal at 80° C 98
4.9 SAXS from a 7% (w/v) ACA-trp gel (pH 7.6, 25° C, after annealing),
representative plot for modified Guinier analyses of gels 100
xv
4. 10 Modified Guinier analyses of simulated scattering data for dimer ( ),
trimer (««), and tetramer (._._.) helical bundles ' 102
4.1 1 Modified Guinier analyses of experimental data (•) from a 7% (w/v)
ACA-trp gel (pH 7.6, 25° C, after annealing), and simulated data ( )
from a tetramer model with a 1 A pore 102
4. 12 Summary of modified Guinier analyses of 7% (w/v) ACA-trp before ()
and after (•) a two minute anneal at 80° C 103
4. 1 3 Summary of both general and modified Guinier analyses
of 7% (w/v) ACA-trp to determine L, before () and after (•)
a two minute anneal at 80° C 104
4. 14 Temperature dependence of Rc for 7% (w/v) ACA-trp samples with
pH 6.5 (A), 7.2 (•), 8.3 (), 9.4 (), and 12 (T) 106
4.15 CD data normalized between zero and complete helical content for
samples at pH 6.45 ( ), pH 7.15 ( ), and pH 9.7 ( ).
The point where the fraction unfolded equals 0.5 approximates Tm 107
4.16 Scattering intensity decreases systematically at pH 8.3 and
sample temperatures of 27° C (•), 41° C (), 55° C ( A),
69°C(T), and80°C(*) 108
4.17 Comparison of CD and SAXS temperature dependence for
a sample at pH 8.3 109
5.1 Fluorescence decay after mixing solutions of ACA-coumarin and
ACA-trp at pH 7.0 118
5.2 Characteristic time constants, Xi (•) and X2 () for strand exchange
in the ACA system as a function of pH 120
5.3 Fluorescence recovery in an ACA gel after photobleaching 121
5.4 Mean square displacement as a function of time for 800 nm
PS probe particles in concentrated ACA-trp solutions at
pH 7.3 (—), pH -9.5 (—), and pH 13 (»«) 123
xvi
LIST OF ABBREVIATIONS
Acetate - OAc
Adenosine triphosphate - ATP
Amino acids:
Three Letter One Letter
Alanine ala A
Arginine arg R
Asparagine asn N
Aspartic acid asp D
Cysteine cys C
Glutamic acid glu E
Glutamine gin Q
Glycine giy G
Histidine his H
Isoleucine ile I
T pnrinp leu L
Lysine lys K
Methionine met M
Phenylalanine phe F
Proline pro P
Serine ser S
Threonine thr T
Tryptophan trp W
Tyrosine tyr Y
Valine val V
2-Amino-2-(hydroxymethyl)-l,3-propanediol - Tris
xvii
2-Amino-2-methyl-l-propanol - AMP
Bovine serum albumin - BSA
Circular dichroism - CD
Deionized - DI
Deoxyribonucleic acid - DNA:
Base One Letter
Adenine A
Cytosine C
Guanine G
Thymine T
Diffusing wave spectroscopy - DWS
Dithiothreitol - DTT
Double distilled water - ddf^O
Ethylenediaminetetraacetic acid - EDTA
Extra cellular matrix - ECM
Fluorescence recovery after patterned photobleaching - FRAPP
Fluorescence resonance energy transfer - FRET
High pressure liquid chromatography - HPLC
Isopropyl (3-D-thiogalactopyranoside - IPTG
Lauryl sulfate sodium salt - SDS
Matrix assisted laser desorption ion mass spectroscopy - MALDI
Molecular weight -MW
National Institutes of Health - NIH
Nuclear magnetic resonance spectroscopy - NMR
xviii
Optical density - OD
Polyacrylamide gel electrophoresis - PAGE
Polyethylene glycol) - PEG
Polystyrene - PS
Polytetrafluoroethylene - PTFE
Refractive index - RI
Ribonucleic acid - RNA
Ribonuclease A - RNase A
Small angle x-ray scattering - SAXS
Time of flight analysis - TOF
Trifluoroacetic acid - TFA
Tris-(2-carboxyethyl)phosphine, hydrochloride - TCEP
*
xix
CHAPTER 1
HYDROGELS, PROTEIN HYDROGELS, AND GENETIC ENGINEERING
A. Motivation
Recent advancements in the biological and material sciences have contributed
greatly towards developing biomaterials. Broadly defined, the term biomaterial includes
any material, natural or synthetic, that originates from, or is compatible with, biological
systems. Natural biomaterials include inorganic (i.e. sea shells, coral reef, and bone),
organic (i.e. silk, wool, and hair), and complex composite (i.e. wood and tissue) systems.
Synthetic materials that demonstrate biocompatibility can also be inorganic (i.e. metals
for bone replacement), organic (i.e. PTFE arterial graft), and composite (i.e. skin graft)
systems. Beyond being biocompatible, pioneering synthetic systems are now capable of
targeting specific interactions within a biological system. The development of organic
based materials that mimic a biological counterpart sits at one frontier of biomaterial
research .
Comprised mostly of water, hydrogels represent a class of material that is likely
most similar to the natural environment found within the human body. For this reason,
hydrogels appear prominently in research efforts towards developing scaffolds for tissue
generation and underlie many investigations for targeted delivery systems
3 " 10
. In
general, polymeric gels fall into two broad categories based on the nature of the crosslink
junction in the network. Chemical gels, as the name suggests, contain crosslink junctions
tied by chemical bonds. Physical gels, in contrast, form via reversible associations of
chain segments, often corresponding to a phase transition such as crystallization or liquid
1
crystal behavior "\12
.
While both classes of gels demonstrate useful properties, physical
gels offer unique advantages for engineering biomaterials.
Due to the reversible nature of the crosslink junctions, physical gels afford greater
flexibility for engineering certain desirable properties. For example, targeted delivery
systems require controlled diffusion of molecules through the network. Physical and
chemical gels alike could provide effective control over diffusion by introducing
associative interactions with the diffusing molecule, engineering physiologically
responsive networks, utilizing degradation, and/or changing molecular weight between
crosslinks
l3 "25
.
However, physical gels demonstrate certain advantages over chemical
gels because they afford the added possibility of controlling the strength of crosslink
associations. This particularly allows finer control over diffusion of molecules larger
than the molecular weight between crosslinks.
Along a similar line of reason, physical gels also provide more opportunities in
the field of tissue engineering. Again, the reversible nature of the crosslinks allows for
controlled diffusion of large molecules (i.e. nutrients and waste), and even provides some
control of cell mobility within the network. Coupled with recent advances in controlling
cellular responses via specific peptide signaling domains 26
~27
,
carefully engineered
physical hydrogels may soon revolutionize medical techniques for tissue repair and
treatment of disease.
B. Foundational Protein Design
Currently, two general methods exist for creating biologically compatible and
active hydrogels. One method incorporates biological functionality within synthetic
2
networks by adsorption, copolymerization, or chemical modification. Polyethylene
glycol), poly(2-hydroxyethylmethacrylate), poly(acrylamide), and poly(N-
isopropylacrylamide) chemical gels typically serve as the synthetic support for these
types of systems. Unfortunately, cells do not respond favorably to the reaction conditions
for most chemical gels hence recent investigations explore milder crosslinking
conditions, both chemical and physical 28 30
.
Another method for creating biologically compatible and active hydrogels
involves using natural polymers such as alginate, collagen or fibrinogen 31-34 While
generally successful in eliciting certain responses, such systems do not provide controlled
response because of the complexities inherent to natural systems. As the scientific
understanding of natural systems evolves, natural polymers will likely become
increasingly prominent in biomaterial research. As this understanding develops, a
complementary route to engineering hydrogels engages the design and biosynthesis of
artificial proteins.
Genetic engineering, or recombinant DNA, technology affords the design and
synthesis of unique proteins not found in natural systems 35 . In general terms, the
approach is straightforward, simple, and yet beautifully ingenious. The first step targets
minimal protein domains or peptide sequences that provide desired activities, structures,
or physical properties. Identification and synthesis of the oligonucleotide sequences that
encode these targeted peptide sequences create a library of artificial genes for building
unique protein structures. Each oligonucleotide follows standard procedure for ligating
the genes into previously digested cloning vectors. Transformation of this cloning vector
library into a library of bacterial hosts generates renewable sources for the targeted genes.
3
Sequential digestions, ligations, and transformations build up a larger gene that may
encode a highly repetitive and/or multi-domain protein. Upon verification of the final
gene sequence in the cloning vector, a final series of digestion, ligation, and
transformation transfers the artificial gene to an expression vector and host
microorganism. Finally, the bacterial host expresses the newly designed gene producing
an artificial protein for further study. Chapter 2 provides a complete explanation of the
experimental procedures for protein biosynthesis.
The foundational design of the protein described herein evolved from two
independent projects. One project focused on the solution properties of the beta-sheet
forming peptide repeat [(ala-gly)x-glu-gly] y
36
. During the course of these studies, the
slightly varied sequence, [(ala-gly)3-pro-glu-gly] y , did not demonstrate any measurable
secondary structure in aqueous solution
37 ~38
. This unstructured peptide sequence,
repeated ten times, shall hereafter be referred to as the random coil domain, or as the
letter C in artificial protein nomenclature. Another project developed artificial protein
sequences following the well-studied leucine zipper motif
39 ~40
.
Leucine zippers fall
within a unique class of 7 2-helix forming proteins in that they self-associate under proper
conditions of pH and temperature 41 . An artificial protein comprised of self-associating
helical domains and a random coil domain serves as the basis for this dissertation.
Hydrophobic and electrostatic interactions drive the self-association of leucine
zippers as dictated by the amino acid sequence. Figure 1.1 pictures a 7 2 helix using the
common helical wheel schematic where the NH2-terminal residue begins at position a,
and the peptide sequence spirals down the helical axis.
4
eFigure 1.1 Helical wheel representation of a 7 2 helix.
Following this representation, primarily hydrophobic amino acids (i.e. leu, ile, and val)
occupy the a and d positions while charged amino acids (i.e. glu, asp, and lys) occupy
select e and g positions. The positioning of these amino acid residues creates a
hydrophobic face along the axis direction. In aqueous solution, leucine zippers associate
to pack the hydrophobic residues into a core surrounded by the more hydrophilic charged
residues. Depending on the particular amino acid sequence, this association can occur as
parallel or antiparallel
42
dimers, trimers or tetramers
4
as illustrated by Figures 1.2, 1.3,
and 1.4, respectively.
Figure 1.2 Schematic illustration of a) parallel and b) antiparallel dimer
coiled-coils.
5
a) b)
Figure 1.3 Schematic illustration of a) parallel and b) antiparallel trimer
helical bundles.
a) b)
Figure 1.4 Schematic illustration of a) parallel and b) antiparallel tetramer
helical bundles.
In addition to directing strand orientation, the particular amino acid sequence
controls other properties of leucine zippers. Thermal and pH melting transitions, free
energy of association, and kinetic strand exchange all intricately depend on the sequence
44-49
of amino acids, particularly those amino acids in the a, d, e, and g positions
Together with recombinant DNA techniques for protein biosynthesis, this dependence
allows precise control over the self-association of artificial leucine zipper proteins
or
protein domains.
6
The original artificial protein hydrogels developed by Petka et al. capitalized on
the self-associative behavior of leucine zippers to act as physical crosslinks. Using the
genes developed in the two projects described previously, Petka constructed a larger gene
encoding a multi-domain protein comprised of two helical domains flanking a single
random coil domain. Several variations of this general helix-coil-helix design exist as
illustrated schematically in Figure 1.5. One group of proteins with primarily acidic
residues at the e and g positions, designated ACA, serves as the primary focus of artificial
protein hydrogel studies
5
"
5I
.
Figure 1.5 Schematic illustration of helix-coil-helix protein design.
Hypothetically, this "triblock" protein design will form a network structure given the
fulfillment of two conditions: 1) concentration of protein exceeds the overlap
concentration, and 2) the helices must associate in bundles of three or more. If the helical
domains associate as dimers, the protein should behave as a macromonomer. In this case,
solutions would not generate networks but would only generate high molecular weight,
linear macromolecules.
Figure 1.6 illustrates a hypothetical hydrogel structure within a concentrated
protein solution assuming the leucine zipper domains associate as tetramers helical
7
bundles. Of course, a number of other possible structures exist including a similar picture
with only trimer helical bundles.
Figure 1.6 Schematic illustration of hypothetical gel structure.
The hypothesis originally presented by Petka et al. suggested a distribution of dimer,
trimer, and tetramer states. Other possible structures altogether dismiss the associative
behavior of the leucine zipper domains and treat the system as a triblock polymer in a
selective solvent for the central block. This hypothesis has merit based upon
observations that leucine zippers are not soluble at high concentrations. Irrespective of
the correct hypothesis, the desire to engineer hydrogels for medical treatments demands a
complete and accurate depiction of the gel structure.
Even though all the possible structures could provide a foundation for
groundbreaking research, the structures that truly capitalize on leucine zipper interactions
as crosslinks hold the most promise. DNA recombinant technology allows precise
8
control over amino acid sequence (i.e. molecular structure). Amino acid sequence
governs the associative behavior of leucine zippers. Helical bundles act as crosslink
junctions and physical crosslinks control the macroscopic properties of physical gels.
This progression of statements suggests that the desired gel structure, pictured in Figure
1.6, would allow precise molecular design and engineering of physiologically pertinent
hydrogels.
C. Goals
This dissertation strives to build three distinct projects on the foundation
established by Petka et al. The first project incorporates a new peptide sequence into the
original helix-coil-helix design that targets a specific biological activity. A number of
activities hold promise for future applications including: cell adhesion domains for tissue
engineering, enzyme domains for biosensors, and domains susceptible to proteolytic
activity for directed delivery systems. While Chapter 2 describes in detail the reasons for
pursuing the latter of these activities, demonstrating compatibility between gel structures
and designed activities drives the effort. Chapter 3 details experimental evidence
demonstrating targeted biological activity in modified ACA and other model systems.
The second and third projects seek to elucidate the gel structure to provide direction for
future engineered hydrogel systems. Chapter 4 provides evidence supporting the static
picture of gel structure illustrated in Figure 1.6, while Chapter 5 reports preliminary
experimental results indicating a dynamic gel structure. Chapter 5 concludes with
suggestions for possible avenues of future exploration.
9
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CHAPTER 2
SYNTHESIS OF GENETICALLY ENGINEERED PROTEINS WITH SITE-SPECIFIC
BIOLOGICAL ACTIVITY
A. Introduction and Objectives
Recent scientific literature abounds with examples of specific biological activity
introduced into polymeric systems. Almost all of these efforts involve surface
modification with proteins or protein domains. Biologically active hydrogels, by
comparison, remain a relatively unexplored type of system. Wide-ranging potential
activities deserve exploration including: catalysis, inhibition, protein recognition, and
cell signaling of adhesion, migration, division, and differentiation. Incorporation of these
activities into hydrogels could eventually lead to the development of scaffolds for
artificial organs, advanced delivery systems, and biosensors
13
°.
Efforts described herein target enzymatic activity, specifically the incorporation
of a domain susceptible to digestion by thrombin. Selection of enzymatic activity follows
the fulfillment of three criteria. First, adequate characterization of enzymatic activity
requires time, skills, and equipment consistent within the scope of this dissertation.
Second, enzymatic digestion affords another, albeit irreversible, means for destroying the
gel in addition to pH and temperature. Finally, incorporating the cleavage site at each
end of the random coil domain provides a possible means to isolate aggregated helices.
Selection of the enzyme thrombin also follows the fulfillment of three criteria.
First, neither the helical nor random coil domains in Petka's original design
31
contain a
site susceptible to thrombin activity. Second, a solid precedent exists which
utilizes
thrombin for cleaving fusion proteins (Novagen™, Madison, WI). Third, thrombin
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critically participates in the natural cascade of events leading to blood clotting; a fact that
suggests thrombin-digested hydrogels could have direct application to wound healing
treatments.
Thrombin, a known endopeptidase, selectively hydrolyzes the arginine-glycine
peptide bond 32
.
Petka's original triblock proteins do not contain this sequence so its
incorporation somewhere within the protein should allow site-specific cleavage. As such,
target proteins contain the hexapeptide sequence, leu-val-pro-arg-gly-ser, used by
Novagen™ for cleaving fusion proteins. The DNA sequence encoding this hexapeptide,
CTG GTG CCA CGC GGT AGC, also follows that of the Novagen™ construct.
Following Petka's original ACA design, Figure 2.1 illustrates the target protein,
designated ATCTA, and the proposed response to thrombin. Likewise, Figure 2.2
illustrates a proposed gel structure and response to thrombin.
Figure 2.
1
Schematic illustration of ATCTA and the proposed response to
thrombin.
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Figure 2.2 Schematic illustration of a hypothetical ATCTA gel structure and
the proposed response to thrombin.
Although Figures 2.1 and 2.2 picture the ATCTA design as symmetric, the
protein actually presents two unique sites for thrombin activity. One site lies closer to the
helical domain as a natural consequence of the recombinant strategy used to construct the
gene encoding ATCTA. Protein configuration may limit, enhance, or not affect at all the
accessibility of one site relative to the other. A complete understanding of enzymatic
activity in ATCTA hydrogels requires a full exploration of such possibilities. To this
end, Chapter 2 reports the design, recombinant strategy, synthesis, and purification of the
thrombin cleavable protein series: C-cys (a negative control), ATC-cys and CTA-cys
(single site controls), ATCTA-trp and ATCTA-cys (network forming proteins), and
CTATC-cys (a dual site control that does not form networks).
B. Experimental Methods
B.l. Desien Strategy
Phosphorylation and Annealing ofDNA Oligonucleotides.
Petka's ACioA design 31 serves as a basis for a series of proteins containing a site
for thrombin cleavage. Following Petka's recombinant strategy, coding and noncoding
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strands of oligonucleotides (T) were ordered from Genosys™ with Nhel and Spel
compatible overhangs as shown in Figure 2.3.
Nhel Spel
5' CT AGC CTG GTG CCA CGC GGT AGC A 3'
3' G GAC CAC GGT GCG CCA TCG TGA TC 5
Figure 2.3 Sequence of coding (5'-3') and noncoding (3'-5') DNA for T
incorporated into the Nhel and Spel restriction sites of cloning
vector pWAP-L2. Important restriction sites are underlined.
Oligonucleotide stock solutions were prepared in ddH20 at concentrations of 1 ug/u.L.
Phosphorylation of the 5' ends was accomplished by annealing the following solution at
37° C for 1 hour: 10 [iL each oligonucleotide stock solution, 5 U.L lOx T4 polynucleotide
kinase buffer (700 mM Tris-HCl pH 7.6, 50 mM DTT, 100 mM MgCl 2 ), 1 uL T4
polynucleotide kinase (10 Richardson units), 5 u,L ATP (10 mM), and 19 U.L ddH20.
After one hour, the following were added to the mixture: 2.5 u,L NaCl (4 M), 1.5 u,L
MgCl2 (1 M), and 46 U.L ddH20. This solution was heated in a large water bath to 95° C
and slowly cooled to room temperature overnight. Annealed DNA was then extracted by
vortexing the solution with 100 u,L phenol / chloroform (50:50), centrifuging (5 minutes,
14000g), and removing the top (aqueous) layer of the phase separated mixture. The
aqueous solution of pure, phosphorylated T DNA was stored at -20° C.
Ligation ofT into pWAP-L2
DNA encoding the thrombin cleavage site was ligated into the pWAP-L2 cloning
vector digested at the Nhel and Spel sites (pWAP-L2ns). Ligation proceeded by a 16° C
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overnight incubation of the following 20 \xL mixture: 1 uL pWAP-L2ns (-0.2 u.g/u.L),
1 uL T DNA (-0.2 \ig/nL), luL T4 DNA ligase (30 Weiss units), 2 uL lOx T4 DNA
ligase buffer (500 mM Tris-HCl pH 7.5, 100 mM MgCl 2 , 100 mM DTT, 10 mM ATP,
250 ng/mL BSA), and 15 uL ddH20. The ligation mixture was transformed into
competent DH5aF' cells immediately following incubation. The target plasmid from this
procedure was designated pUC18-L2T.
General Procedurefor Transformation ofLigation Mixtures into Competent Cells.
Competent cells were thawed on ice from frozen stock. A 50 uL aliquot of cells
was mixed with 5 uL ligation mixture and incubated on ice for 45-60 minutes. Cells
were then heat-shocked at 42° C for 2-3 minutes followed by another 5 minutes on ice.
Cells were then provided 0.5 mL 2xYT medium and incubated at 37° C for 30 minutes.
Cultures were then spread onto agar plates containing 200 (J.g/mL ampicillin and
incubated at 37° C overnight. Resulting colonies were mini-prepped and screened for the
appropriate insert.
General Protocolfor Plasmid Mini-Prepfrom Frozen Stock or Single Colony.
A 5 mL culture was inoculated either from a frozen stock or with a single colony
from an agar plate. After incubation at 37° C overnight, a 3 mL aliquot of the saturated
culture was centrifuged (-2 minutes, 13000g). After removal of the supernatant, the cell
pellet was resuspended in 200 uL GTE buffer (25 mM Tris-HCl pH 8, 50 mM Glucose, 1
mM EDTA) by repeated pipetting. The resuspension was then mixed by gentle inversion
with 200 uL of a SDS (1%), NaOH (0.2 M) solution and incubated on ice for 5 minutes.
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Following incubation, 200 \iL of a NaOAc solution (3 M, pH adjusted to 4.8 with glacial
acetic acid) was added and mixed by vigorous shaking thereby forming a white
precipitate. The mixture was centrifuged (20 minutes, 13000g) to pellet the precipitate.
The clear supernatant was then transferred to a fresh tube containing 2 RNase A stock
solution (10 mg/mL) and then incubated at 50° C for 30 minutes. After incubation,
500 (J.L phenol / chloroform (50:50) was added and mixed thoroughly by vortexing.
Following centrifugation (5 minutes, 13000g), the top (aqueous) layer was transferred to
a fresh tube containing 500 u,L isopropyl alcohol. The new mixture was vortexed and
incubated at -20° C for 30 minutes. Centrifugation (4° C, 30 minutes, 13000g) pelleted
the precipitated DNA, which was then isolated by complete removal of the supernatant.
DNA was then resuspended in 100 U.L ddH20 and mixed by vortexing with 50 u.L of a
PEG (25%, MW 8000), NaCl (2.5 M) solution. Following a 30-minute incubation at -20°
C, precipitated DNA was again isolated by centrifugation (4° C, 30 minutes, 13000g) and
complete removal of the supernatant. Pure plasmid DNA was then resuspended in 50 U.L
ddH20 and stored at -20° C for future use.
Screeningfor Properly Oriented Insertion ofT into pWAP-L2.
Potential pUC18-L2T plasmids were first screened for insertion by digestion with
BamHI restriction enzyme. Restriction digestions were performed by mixing the
following: 10 jxL plasmid (-0.2 \ig/\iL), 2 uE BSA (1 mg/mL), 2 uL lOx NEBuffer
BamHI (100 mM Tris-HCl pH 7.9, 1.5 M NaCl, 100 mM MgCl 2 , 10 mM DTT), 0.25 uL
BamHI (5 units), and 5.75 \jlL ddH20. After incubating at 37° C for -2.5 hours, 4 uL gel
loading Buffer III (25 mg bromophenol blue, 25 mg xylene cyanol FT, 7 mL ddH20, 3
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mL glycerol, filtered solution) was added and digestion results were visualized on a 2%
agarose gel with ethidium bromide. A pBR322 DNA - Mspl digest standard was also run
on the gel in order that plasmids with the proper insertion could be identified by a 68 base
pair fragment from the BamHI digest.
Because the Nhel and Spel overhangs are identical, T could ligate into pWAP-
L2ns with two orientations. The target orientation ligates the Nhel overhang of T with
the Nhel overhang of pWAP-L2ns and likewise with the Spel overhangs. Improper
orientation ligates Nhel overhangs with Spel overhangs, thereby resulting in a plasmid
with neither digestive site remaining. Therefore, plasmids previously identified as having
the proper size insert were screened for orientation by digestion with Nhel and Spel
restriction enzymes. Restriction digestions were performed by mixing the following:
20 \xL plasmid (-0.2 [ig/\xh), 3 [iL BSA (1 mg/mL), 3 uL lOx NEBuffer 2 (100 mM
Tris-IJCl pH 7.9, 500 mM NaCl, 100 mM MgCl 2 , 10 mM DTT), 0.25 uL Nhel (1.25
units), 0.25 ^iL Spel (1.25 units), and 3.5 [iL ddH20. After incubating at 37° C
overnight, 6 \iL gel loading Buffer III was added and digestion results were visualized on
a 2% agarose gel with ethidium bromide. Plasmids with properly oriented T insert
demonstrated a 28 base pair fragment from the Nhel and Spel digests.
After identifying a plasmid with correct insertion and orientation, the DNA
sequence was confirmed using the Sanger dideoxy method
33
and the USB Sequenase
Version 2.0.1™ sequencing protocol
34
. Primers used were the M13/pUC Sequencing
Primer #1212 (-40) and the M13/pUC Reverse Sequencing Primer #1233 (-48). Cloning
plasmid containing properly inserted T was designated pUC18-L2T.
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Ligation ofRandom Coil Sequence DNA into pWAP-L2
DNA encoding the random coil domain (C) was obtained by Nhel and Spel
restriction digests of Petka's pQE9-LlC plasmid. Digests were carried out as described
previously for pUC18-L2T screening. Digestion solutions were visualized on a 1%
agarose gel with ethidium bromide and the proper band was excised using a razor blade.
DNA was then extracted and purified from the gel band using a Qiaex® II Gel Extraction
Kit. DNA was then ligated into pWAP-L2ns following the protocol described
previously. As with pUC18-L2T, the ligation mixture was transformed into competent
DH5ccF' cells which were then spread onto agar plates. Resulting colonies were mini-
prepped and plasmids were screened for proper insertion (BamHI restriction digest) and
proper orientation (Nhel and Spel restriction digests). Cloning plasmid containing
properly inserted C was designated pUC18-L2C.
Preparing a DNA Libraryfor the Thrombin Cleavable Protein Series.
The following plasmids were mini-prepped from frozen stocks: pUC18-L2T,
pUC18-L2C, pWAP-L2A, and pWAP-LlA. A recombinant scheme slightly different
from that reported by Petka utilized the single Ndel restriction site 442 base pairs
downstream of the Spel site. The new scheme reduces the number of steps necessary for
building up new constructs because a single BamHI restriction digest screens for both
proper insertion and orientation. Following this experimental section, Figures 2.4 - 2. 1
1
illustrate the recombinant scheme for constructing plasmids encoding the thrombin
cleavable protein series.
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Ndel restriction digests were performed on pUC18-L2T, pWAP-L2A, pWAP-
L1A, and pUC18-L2C under the following conditions: 25 U.L plasmid (-0.2 u.g/uL), 5
\ih lOx NEBuffer 4 (200 mM Tris-OAc pH 7.9, 500 mM KOAc, 100 mM Mg(OAc)2 , 10
mM DTT), 1 |aL Ndel (20 units), and 19 uL ddH20. Spel restriction digests were
performed on pWAP-L2A and pUC18-L2C under the following conditions: 25 uL
plasmid (-0.2 ng/\iL), 5 \iL lOx NEBuffer 2, 5 uL BSA (1 mg/mL), 1 uL Spel (5 units),
and 14 |iL ddH20. Simultaneous Nhel and Spel digestions were performed on pUC18-
L2C under the following conditions: 25 uL plasmid (-0.2 lag/pL), 5 uL lOx NEBuffer 2,
5 |J.L BSA (1 mg/mL), 1 \iL Nhel (5 units), 1 uL Spel (5 units), and 13 [iL ddH20. Ndel
linearized pUC18-L2T, pWAP-L2A, pWAP-LlA, and pUC18-L2C, Spel linearized
pWAP-L2A and pUC18-L2C, and C DNA were obtained from the above digestion
solutions according to the following standard protocol. After incubating at 37° C
overnight, digestion mixtures were supplemented with 10 \iL gel loading Buffer III and
visualized on a 1% agarose gel with ethidium bromide. Bands were excised and DNA
was extracted using a Qiaex® II Kit.
Ndel linearized pUC18-L2T, pWAP-L2A, pWAP-LlA, and pUC18-L2C were
subsequently digested with Nhel under the following conditions: 25 uL plasmid (-0.2
Hg/HL), 5 uL lOx NEBuffer 2, 5 uL BSA (1 mg/mL), 1 ^L Nhel (5 units), and 14 uL
ddH20. Following standard protocol, these restriction digestions resulted in L2T, L2A,
L1A, and L2C linear DNA inserts, respectively.
Spel linearized pWAP-L2A and pUC18-L2C were subsequently digested with
Ndel under the following conditions: 25 uL plasmid (-0.2 y.g/\xL), 5 uL lOx NEBuffer
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4, 1 \iL Ndel (20 units), and 19 p.L ddH20. Following standard protocol, these restriction
digestions resulted in A-vector and C-vector linear DNA, respectively.
Construction ofpUC18-L2ATand pUC18-L2CT.
Two ligation mixtures were prepared under the following conditions: 2 uL
vector (1 mixture with A-vector and 1 with C-vector), 6 uL L2T, 2 u.L lOx T4 DNA
ligase buffer, 1 p.L T4 DNA ligase (30 Weiss units), and 1 1 p.L ddH20. After overnight
incubation at 16° C, mixtures were transformed into competent DH5ccF' cells. Proper
insert and orientation were verified by BamHI restriction digest under conditions
described previously. A single digestion was sufficient for screening because the only
favorable way for L2T to insert into the vector was for the two Ndel overhangs to ligate,
and for the Spel overhang of the vector to ligate with the Nhel overhang of L2T.
Unwanted inserts might have included the unfavorable reverse orientation, or the vector
self-ligating. In any case, a BamHI restriction digest distinguished between all
possibilities. Cloning plasmid containing proper insert of L2T into A-vector was
designated pUC18-L2AT, and cloning plasmid containing proper insert of L2T into C-
vector was designated pUC18-L2CT.
Construction ofpUC18-L2ATC and pUC18-L2CTA.
Cloning plasmid pUC18-L2AT was digested with the restriction enzyme Spel
under the following conditions: 25 p.L plasmid (-0.2 ng/p:L), 5 p.L lOx NEBuffer 2, 5 pJL
BSA (1 mg/mL), 1 uL Spel (5 units), and 14 \xh ddH20. Cloning plasmid pUC18-L2CT
was simultaneously digested with the restriction enzymes Ndel and Spel under the
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following conditions: 25 pL plasmid (-0.2 pg/pL), 5 pL lOx NEBuffer 2, 5 pL BSA (1
mg/mL), 1 pL Ndel (20 units), 1 pL Spel (5 units), and 13 pL ddH20. Following
standard protocol, these restriction digestions resulted in L2AT-vector and CT-vector
linear DNA, respectively.
Two ligation mixtures were prepared under the following conditions: 2 pL lOx
T4 DNA ligase buffer, 1 pL T4 DNA ligase (30 Weiss units), and 1 1 pL ddH zO. To one
mixture was added 2 pL L2AT-vector and 6 pL C, and to the other mixture was added 2
pL CT-vector and 6 pL L2A. After overnight incubation at 16° C, mixtures were
transformed into competent DH5odF' cells. Plasmids were screened for proper inserts by
BamHI restriction digests. For L2A insertion into CT-vector the BamHI digest also
served to verify proper orientation as previously described. For C insertion into L2AT-
vector a second restriction digest using Nhel and Spel was performed to screen plasmids
for proper orientation. The procedure for this screening followed that described
previously for the screening of T into pWAP-L2. Cloning plasmid containing proper
insert of C into L2AT-vector was designated pUC18-L2ATC, and cloning plasmid
containing proper insert of L2A into CT-vector was designated pUC18-L2CTA.
Construction ofpUC18-L2ATCT andpUC18-L2CTAT.
In two separate reactions, cloning plasmids pUC18-L2ATC and pUC18-L2CTA
were simultaneously digested with the restriction enzymes Ndel and Spel under the
following conditions: 25 pL plasmid (-0.2 pg/pL), 5 pL lOx NEBuffer 2, 5 pL BSA (1
mg/mL), 1 pL Ndel (20 units), 1 pL Spel (5 units), and 13 pL ddH20. Following
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standard protocol, these restriction digestions resulted in ATC-vector and CTA-vector
linear DNA, respectively.
Two ligation mixtures were prepared under the following conditions: 2 u.L
vector (1 mixture with ATC-vector and 1 with CTA-vector), 6 uL L2T, 2 u.L lOx T4
DNA ligase buffer, 1 jxL T4 DNA ligase (30 Weiss units), and 1 1 uL ddH20. After
overnight incubation at 16° C, mixtures were transformed into competent DH5aF' cells.
Plasmids were screened for proper insert and orientation by BamHI restriction digests as
described previously. Cloning plasmid containing proper insert of L2T into ATC-vector
was designated pUC18-L2ATCT, and cloning plasmid containing proper insert of L2T
into CTA-vector was designated pUC18-L2CTAT.
Construction ofpUC18-LlATCTA, pUC18-L2ATCTA andpUC18-L2CTATC.
In two separate reactions, cloning plasmids pUC18-L2ATCT and pUC18-
L2CTAT were simultaneously digested with the restriction enzymes Ndel and Spel under
the following conditions: 25 uL plasmid (-0.2 u.g/uL), 5 U.L lOx NEBuffer 2, 5 U.L BSA
(1 mg/mL), 1 U.L Ndel (20 units), 1 uJL Spel (5 units), and 13 uL ddH20. Following
standard protocol, these restriction digestions resulted in ATCT-vector and CTAT-
vector linear DNA, respectively.
Three ligation mixtures were prepared under the following conditions: 2 uJL lOx
T4 DNA ligase buffer, 1 uJL T4 DNA ligase (30 Weiss units), and 1 1 uL ddH20. To the
first mixture was added 2 |xL ATCT-vector and 6 ^iL L1A. To the second mixture was
added 2 U.L ATCT-vector and 6 uL L2A. To the third mixture was added 2 uL CTAT-
vector and 6 L2C. After overnight incubation at 16° C, mixtures were transformed
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into competent DH5odF' cells. Plasmids were screened for proper insert and orientation
by BamHI restriction digests as described previously. Cloning plasmid containing proper
insert of L1A into ATCT-vector was designated pUC18-LlATCTA. Cloning plasmid
containing proper insert of L2A into ATCT-vector was designated pUC18-L2ATCTA
and cloning plasmid containing proper insert of L2C into CTAT-vector was designated
pUC18-L2CTATC.
Recombining into the pQE9 Expression Vector.
In six separate mixtures, plasmids pUC18-L2C, pUC18-L2ATC, pUC18-L2CTA,
pUC18-LlATCTA, pUC18-L2ATCTA, and pUC18-L2CTATC were digested with
BamHI restriction enzyme under the following conditions: 35 [xh plasmid (-0.2 u.g/u.L),
5 uJL BSA (1 mg/mL), 5 p.L lOx NEBuffer BamHI, 0.5 p.L BamHI (10 units), and 4.5 jiL
ddH20. Following standard protocol, these restriction digestions resulted in L2C,
L2ATC, L2CTA, L1ATCTA, L2ATCTA, and L2CTATC linear DNA inserts,
respectively.
BamHI digested Qiagen™ pQE9 expression vector was used from Petka's frozen
stock. Six ligation mixtures were prepared as follows, one mixture for each of the six
inserts above: 2 insert, 1 [iL pQE9 vector (BamHI digested), 2 lOx T4 DNA
Ligase Buffer, 1 |J.L T4 DNA Ligase, and 14 ddH20. Following a 3-day incubation at
16° C the ligation mixtures were transformed into competent Qiagen™ K-12 E. coli.
Strain SGI 3009 containing the repressor plasmid pREP4. Plasmids were prepared from
healthy colonies following the mini-prep protocol described previously except that
cultures were grown in 2xYT media supplemented with ampicillin (200 u.g/mL) and
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kanamycin (25 M-g/mL). Plasmids were screened for proper insert by simultaneous
digestion using EcoRI and Hindlll restriction enzymes under the following conditions:
10 \iL plasmid (-0.2 ng/\xh), 2 lOx NEBuffer EcoRI (1 M Tris-HCl pH 7.5, 500 mM
NaCl, 100 mM MgCl 2 , 0.25% Tnton X-100), 0.25 uL EcoRI (5 units), 0.25 u.L Hindlll
(5 units), and 7.5 \ih ddH20. Plasmids were screened for proper orientation by digestion
using Nhel restriction enzyme under the following conditions: 10 \xL plasmid (-0.2
M-g/M-L), 2 \iL lOx NEBuffer 2, 2 uJL BSA (1 mg/mL), 0.25 uL Nhel (1.25 units), and 5.75
|^L ddH20. After incubating at 37° C for 3 hours, 4 \xL gel loading buffer III was added
to all screening mixtures and results were visualized on a 2% agarose gel. Identification
of desired pQE9 expression plasmids followed reason described previously.
B.2. Protein Expression and Purification
Six artificial proteins, designated C-cys, ATC-cys, CTA-cys, ATCTA-trp,
ATCTA-cys, and CTATC-cys, were expressed from the previously identified colonies
containing pQE9 plasmids with inserts L2C, L2ATC, L2CTA, L1ATCTA, L2ATCTA,
and L2CTATC, respectively. Small 5 mL cultures were inoculated from frozen stocks in
2xYT media. After incubation at 37° C overnight, saturated 1 mL aliquots were used to
inoculate a 100 mL culture in 2xYT media. All media were supplemented with
ampicillin (200 mg/L) and kanamycin (25 mg/L). Once inoculated, 100 mL cultures
were incubated at 37° C until optical densities (600 nm, OD6oo) reached -0.5. At OD6oo
-0.5, protein expression was induced by the addition of IPTG (1 mM). Aliquots were
removed from the culture before induction and then 45 minutes and 4 hours after
induction to verify controlled expression. After 4 hours, the cell culture was sedimented
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by centrifugation at 15000g for 10 minutes. After removing the supernatant, cells were
resuspended in sonication buffer (50 mM NaH 2P04 , 300 mM NaCl, 10 mM imidazole,
pH 8) and frozen at -20° C. Subsequent scaled-up biosyntheses followed this procedure
exactly, except that a 1 L culture was inoculated by a saturated 1 mL aliquot.
Protein purification began by lysing the cells. Cells were first lysed by thawing,
and then by sonicating for three, one-minute bursts between one-minute incubation
periods on ice. After centrifugation for 20 minutes at 15000g to remove all insoluble
cellular matter, the supernatant was collected for purification. Target proteins were
isolated by loading the supernatant onto a nickelnitrilotriacetic acid resin (Ni2+-NTA,
Qiagen). The pQE9 expression vector encodes a short fusion domain consisting of a
sequence of six histidine residues. This histidine sequence is highly unlikely in a natural
system and demonstrates tremendous affinity towards the Ni 2+-NTA resin. Subsequent
washing of the resin with a series of pH 8 buffers (50 mM NaH2P04 and 300 mM NaCl)
containing 20, 30, and 40 mM imidazole removes all weakly bound proteins because
imidazole presents a competing affinity towards the resin. Target proteins were then
eluted from the resin by washing with 250 mM imidazole buffer. Eluent solutions of
pure protein were dialyzed under continuously refreshing DI water for 3-4 days then
lyophilized.
Further purification was achieved by reverse phase high-pressure liquid
chromatography (HPLC). HPLC was performed on a Waters™ system comprised of a
717plus Autosampler, 486 Tunable Absorbance Detector, and a 600 Controller equipped
with a Nova-Pak® Cis 3.9 x 150 mm column. Proteins were dissolved at concentration
~1 mg/mL in 200 mM Tris buffer, pH 7.4 before injection. Elution profiles were
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collected at a flow rate of 1 mUmin and monitored at 214 nm. The mobile phase began
as water and proceeded through a linear gradient mixture of water and acetonitnle,
ending with acetonitnle. Both solvents contained 0.1% TFA. All solvents were degassed
with helium for 20 minutes before use and were continuously degassed throughout the
procedure. Eluent fractions of HPLC pure protein were collected off the column and
freeze-dried.
B.3. Protein Characterization
Controlled protein expression was verified by polyacrylamide gel electrophoresis
of time dependent culture aliquots. The first 1 mL aliquot was removed immediately
before induction and the other two followed at 45 minutes and 4 hours after induction.
Aliquots were sedimented by centrifugation at 15000g immediately upon removal,
resuspended in -20 \iL ddH20 and stored at -80° C. Upon thawing samples were mixed
with an equal volume of 2x sample buffer (100 mM Tris-HCl pH 8.8, 20% (v/v) glycerol,
4% (w/v) SDS, 0.01% (w/v) Bromophenol Blue) and boiled for 5 minutes. Solutions
were then loaded onto a 14% polyacrylamide minigel. Proteins were resolved by the
method of Laemmli 35 and visualized by staining with Coomassie Brilliant Blue R-250.
B.3.a. Verification of Protein Synthesis
Synthesis of target proteins was verified by quantitative amino acid analysis and
matrix assisted laser desorption ion mass spectroscopy with time of flight analysis
(MALDI-TOF). HPLC purified samples were submitted for both analyses. Samples for
amino acid analysis were submitted to the Analytical Chemistry and Peptide/DNA
28
Synthesis Facility at Cornell University, Ithaca, NY. Samples for MALDI-TOF analysis
were submitted to the Mass Characterization Facility at the University of Massachusetts
Amherst.
B.3.b. Verification of Site Selective Hydrolysis by Thrombin
The five proteins containing a thrombin cleavable site (ATC-cys, CTA-cys,
ATCTA-trp, ATCTA-cys, and CTATC-cys) and three negative controls (C-cys, A-cys,
and ACA-cys) were digested by thrombin under the following conditions: 900 uL
protein solution (~2 mg/mL), 100 u.L lOx buffer (2 M Tris pH 7.4), 5 uL thrombin (1
NIH unit). Reaction mixtures were incubated at room temperature for 5 hours at which
point 100 uL 10% TFA was added to quench the reaction. Resulting solutions were
analyzed by HPLC following the same protocol used in purification. Eluent fractions
were collected off the column and those corresponding to observed peaks were freeze-
dried and submitted for MALDI-TOF at the University of Massachusetts Amherst.
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Figure 2.6 Schematic illustration of A- and C- vector construction.
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35
Figure 2.10 Schematic illustration of pUC18-L2CTATC plasmid construction.
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BamHI
BamHI
Figure 2.11 Schematic illustration of gene transfer from pUC18 cloning
plasmid to the pQE9 expression vector.
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C. Results and Discussion
Upon recombining appropriate DNA into pQE9 expression vectors, transformed
strains exhibited controlled expression of target proteins as demonstrated in Figure 2.12.
The presence of the high copy number plasmid, pREP4, which carries the lad repressor
gene tightly regulates protein expression from the pQE9 expression vector. IPTG
inactivates the lad repressor thereby clearing the T5 promoter upstream of the target
gene and inducing protein expression.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Figure 2.12 SDS-PAGE demonstrating controlled expression at 0, 45, and 240
minutes after induction (left to right) for proteins: C-cys (lanes 2-
4), ATC-cys (5-7), ATCTA-trp (8-10), CTA-cys (11-13), ATCTA-
cys (15-17), and CTATC-cys (18-20). Lanes 1 and 14 contain
molecular weight markers of 68, 43, 18.4, 14.3, and 6.2 kDa.
Initial 1 L cultures expressed the following yields: 68 mg C-cys, 43 mg ATC-cys, 85 mg
CTA-cys, 51 mg ATCTA-trp, 75 mg ATCTA-cys, and 53 mg CTATC-cys.
Quantitative amino acid analysis indicates successful synthesis of target proteins.
Figure 2. 13 shows the target amino acid sequences for the new series of proteins. Tables
2.1 through 2.6 list the amino acid composition measured for each protein along with the
target composition. In all cases, the measured and calculated target percentages of amino
acids agree to within 1 mol %.
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a) MRGSHHHHHHGSDDDDKWASYRDPMG [(A Gj, P EG],0 A
RMPTSMGGC
b) MRGSHHHHHHGSDDDDKWASYRDGDLENEVAQLER
EVRSLEDEAAELEQKVSRLKNEIEDLKAEIGDPRMPT
SLVPRGSTSYRDPMG/(A G)j P E G]w ARMPTSMGGC
c) MRGSHHHHHHGSDDDDKWASYRDPMG [(A G)j P EG] I0 A
RMPTSLVPRGSTSYRDGDLENEVAQLEREVRSLEDE
AAELEQKVSRLKNEIEDLKAEIGDPRMPTSMGGC
d) MRGSHHHHHHGSDDDDKWASYRDGDLENEVAQLER
EVRSLEDEAAELEQKVSRLKNEIEDLKAEIGDPRMPT
SLVPRGSTSYRDPMG [(A G)3 P E G]w ARMPTSLVPRGST
SYRDGDLENEVAQLEREVRSLEDEAAELEQKVSRLK
NEIEDLKAEIGDPRMPTSW
e) MRGSHHHHHHGSDDDDKWASYRDGDLENEVAQLER
EVRSLEDEAAELEQKVSRLKNEIEDLKAEIGDPRMPT
SLVPRGSTSYRDPMG [(A G)s P E G]w ARMPTSLVPRGST
SYRDGDLENEVAQLEREVRSLEDEAAELEQKVSRLK
NEIEDLKAEIGDPRMPTSMGGC
f) MRGSHHHHHHGSDDDDKWASYRDPMG /Y/i G)s P E G]w A
RMPTSLVPRGSTSYRDGDLENEVAQLEREVRSLEDE
AAELEQKVSRLKNEIEDLKAEIGDPRMPTSLVPRGST
S Y R D P M G [(A G)j P E G]w ARMPTSMGGC
Figure 2.13 Target amino acid sequence for a) C-cys, b) ATC-cys, c) CTA-cys,
d) ATCTA-trp, e) ATCTA-cys, f) CTATC-cys. The thrombin
cleavable domain is bold; the random coil domain is italic.
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Amino
Acid
mol%
(calc.)
mol%
(obs.)
Amino
Acid
mol%
(calc )
mol%
IODS. )
ala 25.4 25.4 leu 0 0
cys 0.8 0.7 met 3.2 2.9
asp & asn 4.0 4.1 pro 9.5 9.7
glu & gin 7.9 8.0 arg 2.4 2.4
pne 0 0 ser 3.2 3.2
giy 35.7 36.3 thr 0.8 0.8
his 4 8T". O A 8 « .-.1val 0 0
ile 0 0 trp 0.8 N/M
lys 0.8 0.8 tyr 0.8 0.8
Table 2. 1 Amino acid composition analysis of C-cys.
Amino mol% mol% Amino mol% mol%
Acid (calc.) (obs.) Acid (calc.) (obs.)
ala 19.3 19.0 leu 3.7 3.9
cys 0.5 0.3 met 2.7 2.7
asp & asn 6.4 6.6 pro 8.0 8.1
glu & gin 12.3 12.6 arg 4.8 4.9
phe 0 0 ser 4.8 4.9
giy 25.7 25.6 thr 1.6 1.6
his 3.2 3.3 val 2.1 2.1
ile 1.1 1.1 trp 0.5 N/M
lys 2.1 2.2 tyr 1.1 1.1
Table 2.2 Amino acid composition analysis of ATC-cys.
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Amino
Acid
mol%
(calc.)
mol%
(obs.)
Amino
Acid
mol%
(chIc .
)
mol%
ala 19.3 18.8 leu 3.7 3.9
cys 0.5 0.4 met 2.7 2.6
asp & asn 6.4 6.6 pro 8.0 8.1
glu & gin 12.3 12.6 arg 4.8 4.8
phe 0 0 ser 4.8 5.1
giy 25.7 25.6 thr 1.6 1.7
his 3.2 3.3 val 2.1 2.1
ile 1.1 1.1 trp 0.5 N/M
lys 2.1 2.2 tyr 1.1 1.1
Table 2.3 Amino acid composition analysis of CTA-cys.
Amino
Acid
mol%
(calc.)
mol%
(obs.)
Amino
Acid
mol%
(calc.)
mol%
(obs.)
ala 16.3 16.4 leu 5.7 6.4
cys 0 0 met 2.0 1.4
asp & asn 7.7 8.2 pro 7.3 7.4
glu & gin 14.7 13.8 arg 6.1 6.8
phe 0 0 ser 5.7 5.0
giy 20.0 19.5 thr 2.0 2.5
his 2.4 2.6 val 3.3 3.6
ile 1.6 1.9 trp 0.8 N/M
lys 2.9 3.1 tyr 1.2 1.4
Table 2.4 Amino acid composition analysis of ATCTA-trp.
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Amino
Acid
mol%
(calc.)
mol%
(obs.)
Amino
Acid
mol%
(calc.)
mol%
(obs.)
ala 16.1 16.5 leu 5.6 5.5
cys 0.4 0.3 met 2.4 2.5
asp & asn 7.6 7.6 pro 7.3 7.4
glu & gin 14.5 14.3 arg 6.0 5.8
phe 0 0 ser 5.6 5.8
giy 20.6 21.3 thr 2.0 1.9
his 2.4 2.6 val 5.2. 3.U
ile 1.6 1.5 trp 0.4 N/M
lys 2.8 2.8 tyr 1.2 1.2
Table 2.5 Amino acid composition analysis of ATCTA-cys.
Amino
Acid
mol%
(calc.)
mol%
(obs.)
Amino
Acid
mol%
(calc.)
mol%
(obs.)
ala 22.6 22.5 leu 2.7 2.6
cys 0.3 0.2 met 2.4 2.4
asp & asn 4.4 4.3 pro 9.4 9.6
glu & gin 11.1 11.3 arg 4.0 3.9
phe 0 0 ser 4.0 4.0
g'y 30.3 31.0 thr
1.7 1.6
his 2.0 2.0 val 1.7 1.6
ile 0.7 0.6 trp 0.3
N/M
lys 1.3 1.3 tyr 1.0
1.0
Table 2.6 Amino acid composition analysis of CTATC-cys.
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MALDI-TOF results also indicate successful synthesis of target proteins as shown
in Figures 2.14 through 2.19 and summarized in Table 2.7.
Protein Ubs. Mm (Da) Calc. MH (Da) % Error (abs)
C-cys 10752.8 10732 0.19 %
ATC-cys 17626.4 17624 0.014 %
CTA-cys 17622.0 17624 0.011 %
ATCTA-trp 24348.1 24353 0.020 %
ATCTA-cys 24520.0 24515 0.020 %
CTATC-cys 27151.8 26457 2.6 %
Table 2.7 Summary of MALDI-TOF mass spectra.
The measured molecular masses are nearly identical to expected theoretical masses
except in the case of CTATC-cys. The data reveal two points that may explain this
discrepancy. First, the measured mass of C-cys is 21 Da higher than expected which
indicates the presence of other counter ions, particularly sodium, that are difficult to
remove due to the large fraction of acid groups comprising the peptide chain. Second,
the accuracy of MALDI-TOF diminishes as molecular weight increases. There also
exists the possibility of an unexpected genetic mutation but amino acid analysis and
MALDI-TOF of digested CTATC-cys (Figure 2.25 to follow) indicate good agreement
between measured and expected results. Hence the CTATC-cys gene was not sequenced,
and the conclusion drawn that counter ions and inaccurate calibration lead to the mass
discrepancy reported in Table 2.7 for CTATC-cys.
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700 - 5376.5 10752.8
600
500 -
400
300
200
Expected MNa : 10754
5000 10000 15000 20000 25000 30000 m/z
Figure 2.14 MALDI-TOF mass spectrum of C-cys.
1200
1000-
800
600 -
400
200
Expected MH+ : 17624
17626.4
5000 10000 15000 20000 25000 30000 35000 m/z
Figure 2. 15 MALDI-TOF mass spectrum of ATC-cys.
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17622.0
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5000 10000 15000 20000 25000 30000 35000 m/z
Figure 2. 16 MALDI-TOF mass spectrum of CTA-cys.
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Expected MH : 24353
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Figure 2.17 MALDI-TOF mass spectrum of ATCTA-trp.
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1000
800
600
400
200 -
Expected MH + : 24515
12268.6
8178.5
24520.0
5000 10000 15000 20000 25000 30000 m/z
Figure 2.18 MALDI-TOF mass spectrum of ATCTA-cys.
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Expected MH+ : 26457
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Figure 2. 19 MALDI-TOF mass spectrum of CTATC-cys.
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Further HPLC and MALDI-TOF results indicate successful incorporation of the
thrombin cleavable domain and site-selective digestion by the enzyme. Figure 2.20
illustrates a representative HPLC chromatogram before and after exposure to thrombin.
Before digestion, ATC-cys, CTA-cys, ATCTA-trp, ATCTA-cys and CTATC-cys all
elute at -30 minutes, an elution time expected for any molecules containing the leucine
zipper domain. After digestion two peaks are observed. One peak elutes at - 20 minutes,
an elution time demonstrated by the C-cys control, and the other peak elutes at -30
minutes. This result supports, albeit weakly, the presence of site-selective activity within
the molecules.
i
t
V
1
\
time (min.)
Figure 2.20 Representative HPLC chromatogram of thrombin-digested
proteins. Random coil domain elutes at -20 minutes, all proteins
containing a helical domain elute at -30 minutes.
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MALDI-TOF analysis of peak fractions provides further support for site selective
activity. Figures 2.21 through 2.25 report these results along with expected masses from
the enzymatic reaction and are summarized in Table 2.8. Note that Figure 2.22 does not
show a peak near the expected mass of the A-cys fragment. Table 2.8 reports the mass
for this fragment obtained from a separate experiment (figure not shown). The apparent
randomness of peak intensities arises from sample preparation. After exposure to
thrombin, samples were purified by HPLC and individual peak fractions were collected
and combined for each protein. While every attempt was made to collect entire fractions,
some sample fragments may not have been entirely collected.
Protein
Observed fragment
masses (Da)
Calculated fragment
masses (Da)
% Error (abs.)
ATC-cys
8917
8744
8908 (A)
8735 (C-cys)
0.10%
0.10%
CTA-cys
10812
6784
10850 (C)
6793 (A-cys)
0.35%
0.13%
8856 8908 (A) 0.59%
ATCTA-trp 8804 8852 (C) 0.55%
6575 6631 (A-trp) 0.85%
8875 8908 (A) 0.38%
ATCTA-cys 8812 8852 (C) 0.45%
6748 6793 (A-cys) 0.67%
10825 10850 (C) 0.23%
CTATC-cys 4479 (2+) 8735 (C-cys) 2.47%
6865 6910 (A) 0.66%
Table 2.8 Summary of MALDI-TOF mass spectra after exposure to
thrombin.
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ure 2.21 MALDI-TOF mass spectrum of thrombin digested ATC-cys and
the expected fragment masses.
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1000
800
600 -
400
200 -
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10812
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ure 2.22 MALDI-TOF mass spectrum of thrombin digested CTA-cys and
the expected fragment masses.
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Figure 2.23 MALDI-TOF mass spectrum of thrombin digested ATCTA-trp and
the expected fragment masses.
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Figure 2.24 MALDI-TOF mass spectrum of thrombin digested ATCTA-cys
and the expected fragment masses.
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Figure 2.25 MALDI-TOF mass spectrum of thrombin digested CTATC-cys
and the expected fragment masses.
D. Conclusions
SDS-PAGE, quantitative amino acid analysis, and MALDI-TOF results all verify
the successful construction and expression of six artificial genes. The target protein
designs utilize three domains: a domain susceptible to thrombin activity (T), a water-
soluble random coil domain (C), and a helical leucine zipper domain (A). The terminal
cysteine residue present in all but one of the new proteins may prove useful in future
investigations as it provides a unique site for subsequent chemical modifications.
Adsorption of these proteins to gold surfaces, specifically through gold-thiol interactions,
may provide a new framework for biosensor technology. Most importantly, the
successful incorporation of site-specific biological activity affords the possibility of
preparing biologically active hydrogels. At this point, experimental evidence only
supports this possibility/because the gel structure may inhibit the desired activity.
Chapter 3 seeksfoexplore the effects of gel structure on enzymatic activity.
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CHAPTER 3
KINETIC ANALYSIS OF THROMBIN REACTING ON GENETICALLY
ENGINEERED PROTEINS
A. Introduction and Objectives
Chapter 2 demonstrated successful incorporation
of site-selective biological
activity into a series of proteins including
the general, network forming ACA construct.
This success raises the question: do gel structures
affect enzyme activity? Answering
this question requires the investigation of
the entire series of proteins described in
Chapter 2 because the general ATCTA construct contains
two un.que active sites in a
complex network system. Investigation of two
proteins, ATC-cys and CTA-cys, provides
a means for charactenzing each active
site independent of the other. Investigation
of a
third protein, CTATC-cys, allows for the
charactenzation of a molecule containing two
active sites without the added complexity of
possible network structures. These three
control systems (ATC-cys, CTA-cys, and CTATC-cys)
serve as a foundation for
understanding the kinetic behavior of thrombin
acting on ATCTA-trp and ATCTA-cys
solutions and gels.
One standard analysis for enzyme kinetics,
often referred to as a Michaelis-
Menten analysis, makes the following
assumptions about the reaction mechanism
and
scheme. First, the enzyme (E) acts as a
catalyst. Second, the enzyme and a protein
substrate (S) react rapidly to form a single,
reversible enzyme-substrate complex (ES),
which then irreversibly breaks down to form
product (P) and free enzyme. Third, the
substrate concentration is much larger than
the enzyme concentration such that
formation
of the enzyme-substrate complex does
not significantly alter the free
substrate
54
concentration. Finally, the analysis assumes a steady-state equilibrium, meaning the
concentration of the enzyme-substrate complex remains constant until the protein
substrate is nearly exhausted ' ,2 .
Equation 3.1 visualizes the general reaction mechanism assumed for a Michaelis-
Menten analysis.
k
\ k
E + S
(
* ES E + P (Equation 3.1)
From this equation, the rate of formation of product defines the reaction rate. Equation
3.2 establishes the reaction rate in terms of the concentration of enzyme-substrate
complex and the catalytic rate constant, kcat .
= kcat * [ES] (Equation 3.2)
dt
Utilizing the conservation of mass as defined in Equation 3.3 and defining a limiting
maximum rate (Vmax) as shown in Equation 3.4, a new Equation (3.5) for the reaction rate
becomes apparent.
[E],=[E] + [ES] (Equation 3.3)
Vmax =kcat *[E]t (Equation 3.4)
d[P] VmnY *[ES] ,„ . -
—
j_ _ ax—i '_ (Equation 3.5)
dt [EJ + [ES]
55
Rearranging the steady-state approximation as defined by Equation 3.6, grouping the rate
constants as defined in Equation 3.7, and substituting these into Equation 3.5 yields the
Michaelis-Menten Equation (3.8) for the reaction rate.
d[ES]
dt
= 0 = k
l
*[E][S]-(k
cat +k_ l )*(ES] (Equation 3.6)
*1
(Equation 3.7)
d[PJ
=
Vmax *[SJ
dt Km +[S]
(Equation 3.8)
The Michaelis-Menten analysis holds for a surprising number of enzymatic
reactions, including the activity of thrombin on synthetic peptide substrates 2
'4
. Hence,
Chapter 3 utilizes this analytical technique to describe the activity of thrombin on the
newly designed series of artificial proteins.
B. Experimental Methods
B.l. Protein Biosynthesis and Purification
Five proteins were studied to determine the kinetics of thrombin activity within
the gel system: ATC-cys, CTA-cys, ATCTA-trp, ATCTA-cys, and CTATC-cys.
Proteins were prepared by expression of the corresponding artificial gene in an E. coli
host strain SG13009 containing the repressor plasmid pREP4 (Qiagen, Chatsworth, CA).
Construction of the artificial genes in the pQE9 expression plasmid and small-scale
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expressions are described in Chapter 2. Large-scale expressions were carried out to
prepare samples for kinetic analyses.
Small 25 mL cultures were inoculated from single colonies in 2xYT media. After
overnight incubation at 37° C, saturated 25 mL cultures were used, in their entirety, to
inoculate 12 L cultures in lxLB media. All media were supplemented with ampicillin
(200 mg/L) and kanamycin (25 mg/L). Once inoculated, 12 L cultures were incubated at
37° C until optical densities (600 nm, OD6oo) reached one. At OD 6oo>l, protein
expression was induced by the addition of EPTG (1 mM). After 4 hours, the cell culture
was sedimented by centrifugation at 15000g for 10 minutes. Cells were then
resuspended
in sonication buffer (50 mM NaH2P04) 300 mM NaCl, 10 mM imidazole, pH 8) and
frozen at -20° C.
Protein purification began by lysing the cells. Cells were lysed first by
thawing,
and then by sonicating for three, one-minute bursts between one-minute
incubation
periods on ice. After centrifugation for 20 minutes at 15000g to
remove all insoluble
cellular matter, the supernatant was collected for
purification. Target proteins were
isolated from the supernatant by affinity chromatography on a
nickelnitrilotnacetic acid
resin (Ni
2+
-NTA, Qiagen) following the native purification protocol described
in Chapter
2. Eluent solutions of pure protein were dialyzed
under continuously refreshing DI water
for 3-4 days then lyophilized. Yields for all expressions
were 100 ± 20 mg protein per
liter of culture.
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B
-2. Determination of Reaction Rate
Thrombin from human plasma was purchased from Sigma-Aldrich (E280 l% = 18.3)
and stock solutions (0.2 NIH units/uL) were prepared under the following conditions: 20
mM Tns-maleate PH 7.3, 17.1 mM NaCl, 13.3 mM glycine, 27.4 mM manitol, 100
ug/mL BSA, 500 u^g/mL PEG, and 50% (v/v) glycerol. Fresh thrombin stocks were
prepared daily to ensure that enzyme activity was not lost. Stock solutions of proteins
were prepared in 200 mM Tris and pH was subsequently adjusted to 7.4 with 8 N NaOH.
An array of protein solutions with varying concentrations of the thrombin series
proteins were prepared for enzymatic digestion by diluting stock solutions with buffer
(200 mM Tris pH 7.4). Concentrations ranged from 70 mg/mL to 0.1 mg/mL. Thrombin
stock was added to each solution so that the final concentration of enzyme was 1.25 NIH
units per 1 mL reaction solution. Aliquots were removed from reaction vials at six
discrete time intervals and reactions were quenched by addition of TFA to a final
concentration of 1% (v/v). This procedure was repeated three times for low
concentration samples (<5 mg/mL). A similar procedure was carried out for higher
concentrations (>10 mg/mL) only once to conserve the limited protein supply. In order
to compensate for lost statistical significance, aliquots were removed from high
concentration reaction vials at fifteen discrete time intervals. Discrete time intervals
ranged from 2 minutes for the lowest concentration experiments to 10 minutes at the
highest concentration. Quenched reaction aliquots were stored at -20° C and then
analyzed by HPLC.
Gel systems were investigated by annealing 100 uL aliquots of ATCTA-cys (70
mg/mL) for 5 minutes at 75° C, followed by rapid quenching to room temperature.
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Thrombin solution was then dispensed on top of the gel without further mixing. At 10-
minute time intervals, entire 100 uL aliquots were treated with 900 uL, 200 mM Tris pH
13. This high pH served two purposes: inhibiting thrombin, and dissolving the gel.
Quenched reaction vials were stored at -80° C and then analyzed by HPLC.
HPLC was performed on a Waters™ system comprised of a 717plus
Autosampler, 486 Tunable Absorbance Detector, and a 600 Controller equipped with a
Nova-Pak® Ci 8 3.9 x 150 mm column. Elution profiles were collected at a flow rate of 1
mL/min and monitored at 214 nm. The mobile phase began as 100% water and
proceeded through a linear gradient mixture of water and acetonitrile, ending as 100%
acetonitrile. Both solvents contained 0.1% TFA. All solvents were degassed with helium
for 20 minutes before use, and were continuously degassed throughout the procedure.
HPLC profiles of digested proteins demonstrated two distinct peaks as described
in Chapter 2. The random coil domain elutes first, followed by all proteins containing a
helical domain. Hence, the initial appearance and subsequent evolution of the coil peak
over a series of time dependent HPLC profiles provides information concerning the
kinetics of the enzymatic reaction. Analysis of HPLC profiles proceeded as follows.
First, profiles were integrated to determine peak areas and the ratio, R, was
calculated according to Equation 3.9 for each discrete reaction time, t.
R( t ) = ^oil (Equation 3.9)
Aotal
R(t) was then normalized according to Equation 3. 10 to obtain
the fraction digested, F(t).
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R(t)-R0 (Equation 3.10)
F(t) =l^
In Equation 3.10, R0 represents the ratio of
peak areas of a sample before exposure to
thrombin. For ATC-cys, ATCTA-trp,
and ATCTA-cys, Ro was zero. For CTA-cys
and
CTATC-cys, Ro was not zero indicating that
some digestion occurred dunng the
b.osynthetic process. Ro was measured
expenmentally for each protein by analyzing
HPLC profiles of samples before being exposed
to thrombin. R. represents the ratio of
peak areas of a completely digested
sample. This quantity was measured
expenmentally
for each protein by running and analyzing
a senes of 40 HPLC profiles collected from a
S1ngle sample being digested by
thrombin over the course of - 1000 minutes.
R(t) was
plotted against t and the asymptote
defined Roc.
From the fraction digested, the
concentration of the random coil domain, [C(t)],
was calculated according to Equation
3.11 where [S] represents the original
protein
concentration and n represents the number
of random coil domains in the protem.
... .
(Equation 3.11)
lC(l)l=n>lSl* FC>
The final step in detennintng reaction
rate requtred the relationship
between [€(.)] and
the concentration of product, (P(.)l.
Equation 3.12 represents a genera,,
functional for-
of this relation.
(Equation 3.12)
[P(t)] = f{[C(t)]}
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Details of Equation 3.12 as it relates to each protein
are provided in the Results and
Discussion section. Given [P(t)], the initial reaction rate was
calculated according to
Equation 3.13.
d[P(0)] (Equation 3.13)
reaction rate = -
dt
B.3. Determination of Michaelis-Mcnten Kin
etic Parameters
Reaction rates were measured for each protein at
several concentrations. Data
were then plotted as reaction rate vs.
protein concentration and fit to the M.chaelis-
Menten Equation (3.8) to determine the
parameters Vmax and Km . The parameter kcat was
calculated according to Equation 3.4 using an
enzyme concentration of 10.8 nM
determined by the conversion 8.66 x 10
12
mol active thrombin per NIH unit
:5-7
C. Results and Discussion
Discussion begins with the ATC-cys and
CTA-cys systems because they represent
the single-site controls. In addition,
analysis of these systems proceeds along
the most
direct route. Using the terminology of
Equation 3.12, the measurable concentration
of
the random coil domain equals the concentration
of product because a single catalytic
event produces a single random coil domain.
Figure 3.1 shows results from an enzyme
digestion of ATC-cys, representative of
all ATC-cys and CTA-cys reactions. For
these
systems [P(t)] = [C(t)]. Most reports of
enzyme kinetics monitor the reaction
between
0% and 5% of the initial substrate reacted and linear
fits of P(t) provide an accurate
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measure of the initial reaction rate. Experimental conditions and monitoring capabilities
reported herein did not, nor could not capture a significant set of data from the first 5% of
the reaction. Instead, all kinetic data to follow represents a larger fraction of the total
reaction, never more than 65%, still within the boundaries of the steady state
approximation. Because the data cover a larger fraction of the reaction, linear fits no
longer provide an accurate measure of the initial reaction rate because the reaction
slows
down over time as substrate is consumed. Instead, Figure 3.1 demonstrates how data
were fit to a second order polynomial to describe P(t). The slope of the tangent at t=0
then defines the initial reaction rate.
2.5 x 10"
2.0
Figure 3.1
1.5
1.0
0.5
200
Y = ax2 +bx + c
c 3.50e-6
b 2.38e-8
a -5.75e-12
R 0.99984
400 600 800
time (s)
1000 1200
Representative plot for the production of random coil domain.
Data taken from enzyme hydrolysis of ATC-cys (43 uM).
Fitting to a second order polynomial holds no real physical
meaning and may
raise concern over the validity of the analysis. As a test, the
Michaelis-Menten Equation
(3.8) was integrated to provide Equation 3.14. Even
though Equation 3.14 describes the
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function t(P) rather than P(t), it does represent an exact solution and was used in a
spreadsheet to generate several sets of model data.
t=
K
>n
t/fI/ ^0 ) + -^- (Equation 3.14)
Vmax [S]0 -[P] Vmax
Model data were generated using initial substrate concentrations, [S] 0 , of 50 nM and 5
mM, lower and upper limits, respectively, of the experimental conditions. Also, several
values for Vmax and Km were used that spanned those reported for Thrombin in the
literature. In all cases, second order polynomial fits demonstrated a goodness of fit
parameter, R>0.9999, so long as model data beyond 70% substrate consumption were
excluded. In fact, second order polynomial fits provided a more accurate measure of
initial reaction velocity (i.e. the slope of the tangent at t=0) than did linear fits (i.e.
the
slope of the line), regardless of the range of data being fit. Thus, the
unconventional
approach to determine reaction rate is deemed valid.
The data presented in Figure 3.1, and similar data sets for all samples, do not
extrapolate to zero concentration of free coil domains at time zero, i.e. [C(t=0)] + 0.
Data
from reactions run at high protein concentrations extrapolate to <l% of the total protein
concentration. Data from reactions run at low protein concentrations can
extrapolate to
-10% of the total protein concentration in the worst cases. Data from reactions run at
intermediate protein concentrations extrapolate to between 1% and 10% of the total
protein concentration. These unexpected results and the indicated
trend suggest that
localized concentration fluctuations may drastically affect reaction
kinetics before the
system mixes to reach steady-state equilibrium. For the purposes
of determining kinetic
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ATC cvs and CTA-cys via M.chaelis-Menten
analysis, the initial proton
parameters on C-cy u ^ i n y
conce„,rat,o„ a,^„ PI, was<>— »«~ "»
time concern, tC(,=0)],
tan ,he s.an.ng protein conce„,
ra„o„ in .he ,eac„o„
vessel.
Flgure 3.2 summanzes
the initial reaction rates
measured at varying
f ATC cvs and CTA-cys. The
logarithmic abscissa allows
clear
concentrations o 1 - y u ^ ^ }
systems with identical kinetic
efficiency.
10-6 10
Figure 3.2 Michaelis-Menten
ana
[S] (M)
lysis of ATC-cysC) and CTA-cys
().
Knowing that the enzyme
reacts with each sitei
dentically, discussion
proceeds to
the CTATC-cys protein.
Although CTATC-cys
contains twos ites, analyses
of data begin
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by following the previous protocol. As with ATC-cys and CTA-cys, the concentration of
random coil domain equals the concentration of product because each catalytic event
produces a random coil domain. Consequently, Figure 3.1 accurately represents raw data
collected and analyzed from enzymatic digestion of CTATC-cys. Again, data do not
extrapolate to [C(t=0)] = 0, but the correction for initial substrate concentration at
equilibrium was more involved because each protein molecule contains two reactive
sites. Does proper analysis define the substrate concentration based on the number of
protein molecules containing an active site, or the total number of active sites?
Figure 3.3 shows CTATC-cys data plotted according to both possibilities along
with fits to Equation 3.8.
8x 10'8 r
[Protein]
[Sites] •
•V
10
Vmax 7.45e-8 Vmax 7.45e-8
8.37e-5
•
/ ;
Km 1.67e-4
A
7 10'
6 10"5 lO"
4 10"3 10"2 1
[S] (M)
Figure 3.3 Michaelis-Menten analysis of CTATC-cys plotted according to
protein concentration (•) and reactive site concentration ().
For [S] representing the concentration of protein molecules, initial
substrate
concentration was adjusted according to the probability that a random cleaving of
sites
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results in both sites on a single CTATC-cys molecule
being cleaved. This modification
must be considered because a single cleaving
event does not reduce the total number of
molecu.es containing an active site. For
example, if 100 CTATC molecules are cleaved
by Thrombin, the first event produces
fragments of CTA and C. Even though one coil is
detected, 100 molecules with an active s.te
st.ll remain. If the probability of the next
event occurring on the CTA fragment is equal to that
on the CTATC molecule, a
statistical analysis predicts that 15 C fragments will
be detected before the number of
molecules containing an active site drops
to 99. Thus, initial substrate concentration
was
determined by subtracting/*[C(t=0)] from the
starting protein concentration, where/
represents the appropriate factor determined
by statistical probability. For [S]
representing the concentration of reactive
sites, initial substrate concentration
was
determined by subtracting [C(t=0)] from
twice the starting protein concentration
(two
sites per molecule) in the reaction vessel.
The fits indicate exactly the expected
behavior. The maximum reaction rate
remams fixed because it depends only
on and enzyme concentration,
independent of
any substrate effects. The MtchaeHs-Menten
parameter, Km , changes by a factor of two;
a result expected by algebra,
rearrangement of the Equations 3.15, 3.16,
3. 17 and3.18.
(Equation 3.15)
[site] =2* [protein]
[E][ protein ] (Equation 3.16)
Km,[ protein i ~ r £ • protein ]
[ E [[site } (Equation 3.17)
KmJ site] = rE»site]
,
(Equation 3.18)
[E» protein] =[ E» site]
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The terms [E • protein] and [E • site] represent the concentrations of enzyme-protein and
enzyme-site complexes, respectively. Equations 3.16 and 3.17 hold true at the initial
establishment of equilibrium. Equation 3.18 represents a valid approximation
considering the probability that two enzymes would, or even could, form a complex with
a single CTATC-cys molecule.
Comparing the Michaelis-Menten parameters reported in Figures 3.2 and 3.3
provides some insight for understanding Thrombin activity on a protein containing more
than one active site. If the analysis uses protein concentration to determine the reaction
parameters (Km = 76.3 [iM and 83.7 uM for single- and dual- site molecules,
respectively), the enzyme binding efficiency appears to be similar for single-site and
dual-site molecules. If the analysis uses site concentration to determine the reaction
parameters (Km = 76.3 and 167 |iM for single- and dual- site molecules,
respectively), the enzyme appears to lose about half its binding efficiency in a two-site
molecule relative to one-site molecules. In either case, the data indicate that the
formation of the enzyme-substrate complex depends only on the concentration of
molecules regardless of the number of reactive sites within a molecule.
The more substantial variations in Vmax between Figures 3.2 and 3.3 likely arise
from bad statistics at the highest concentrations because these data do not represent an
average of three reactions. In such cases, the measurements of reaction rate represent the
largest source of error because slight differences in enzyme concentration shift data
points vertically, while concentration deviations merely shift data points horizontally
along the asymptotic limit.
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CTATC-cys provides a critical understanding of enzyme activity on a protein
containing two unique sites in a system where d[C(t)]/dt = d[P(t)]/dt. Without this
understanding, a kinetic analysis of ATCTA systems would prove impossible using the
available experimental techniques. Using HPLC to characterize the enzymatic reaction,
the measurable product is the random coil domain. For ATCTA systems, d[C(t)]/dt does
not equal d[P(t)]/dt because a single catalytic event does not produce a random coil
domain. Instead, each catalytic event produces a helical domain, hence d[A(t)]/dt
=
d[P(t)]/dt. Defining a relationship between [A(t)] and [C(t)] requires the understanding
provided by CTATC-cys of enzyme activity on a two-site system.
The relationship between [A(t)] and [C(t)] follows from a simple model based on
two valid assumptions. First, each site within ATCTA reacts with equal probability; an
assumption supported by previous interpretation of ATC-cys and CTA-cys data.
Second,
a single site within ATCTA reacts with half the probability of a single site within a one-
site molecule; an assumption supported by previous interpretation
of CTATC-cys data.
The model develops through the following thought experiment.
Begin the experiment with 100 ATCTA molecules. The probability of the first
catalytic event occurring on ATCTA is equal to 1. Since each site within the
molecule
reacts with equal probability, ATC and CTA form with equal probability.
The second
catalytic event occurs on either ATCTA (99 times out of 100), or on the
product of the
first event (1 time out of 100). Continuing along this
process, Equations 3.19, 3.20, and
3.21 describe the probability of a catalytic event
occurring on a given molecule based on
the distribution of molecules present at any given
time.
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Patcta =
ATCTA
(Equation 3.19)
L ATCTA + ATC + CTA
PiTr =
ATC (Equation 3.20)
a/c ATcta + ATC + CTA
P £™ (Equation 3.21)
atcta + Arc + crA
These equations provide the basis to construct a spreadsheet for calculating the
distribution of species over the 200 catalytic events necessary to completely digest
ATCTA. Figure 3.4 illustrates the results of this model calculation plotted as the fraction
of free helical domains versus the fraction of free random coil domains.
Coil Domains
(fraction of total)
3 4 Empirical relationship between concentration of coil domains
helical domains as ATCTA hydrolyses via enzymatic activity.
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This model provides an empirical relationship between the measured
value, [C(t)], and
the desired value, [A(t)]. Using this relation, d[P(t)] follows from
the previously stated
identity, d[P(t)]/dt = d[A(t)]/dt.
The necessity for this empirical relation becomes evident by
comparison of
Figures 3.5 and 3.6. Both figures illustrate the same data
obtained from a digestion of
ATCTA; Figure 3.5 pictures [C(t)j while Figure 3.6 shows [A(t)] as
determined by the
relation defined in Figure 3.4. Identifying an initial
reaction rate in the context of a
Michaelis-Menten analysis proves useless from data in Figure 3.5.
In contrast, Figure 3.6
represents data used for determining reaction rate in
ATCTA solutions, again by
parabolic fits as descnbed for the previous ATC-cys, CTA-cys,
and CTATC-cys systems.
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Evolution of random coil domains as enzyme
cleaves ATCTA
systems.
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c 1.23e-5
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a -3.79e-12
R 0.99997
1000 1500
time (s)
2500
Evolution of helical domains as enzyme
cleaves ATCTA systems.
Results from Michaelts-Menten analysis
of ATCTA-cys and ATCTA-trp showed
stnlong similarities to ATC-cys,
CTA-cys, and CTATC-cys. As such,
Figure 3.7
summarizes the reaction rates for all
systems at all concentrations, with the
two-site
systems plotted according to the
concentration of protein. As all data fall
along the same
curve, Figure 3.7 includes a fit of
all data to Equation 3.8 to determine
the kinetic
parameters shown in Table 3.1.
Km 77 ± 4 uM
kcat
6.4 ±0.7 s
1
kcat / K.m
0.083 s"
1
uM"'
Table 3 1 Expenmentally
measured kinetic parameters for thrombin
acting
on genetically engineered
multidomam proteins.
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Figure 3.7 Michaelis-Menten analysis for the
newly developed series of
proteins, ATC-cys (•), CTA-cys (), ATCTA (trp & cys) ( A),
and
CTATC-cys ().
Results pictured in Figure 3.7 and listed in Table
3.1 compare favorably to other
reported values for Thrombin in the literature.
However, Thrombin is a complex enzyme
within a complex cascade of biological events
under complex conditions so care must be
taken when comparing kinetic results. A summary of
human Thrombin activity on
synthetic peptide substrates
3 demonstrates a wide range of kinetic parameters
with Km
between 1.5 uM and 2.5 mM and between 0.015 s
< and 220 ,"«. Data from samples
within this summary that more closely
resemble the proteins studied herein exh.bit
Km
between 4.2 ,M and 1800 uM and kcat between 3.1 s
' and 220 s \ still a very w.de range.
Even so, these values compare well with
those measured (77 uM and 6.4 s"
1
)
considering
the differences between substrates and
reaction conditions.
A thorough understanding of the ATCTA system
finally allows an investigation
of enzymatic activity within the gel
structure. However, visual observahon
of a gel
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digestion indicates that data analysis cannot follow the
protocol used for ATCTA
solutions. Visual inspection of the gel sample after exposure
to thrombin reveals an
apparent two-phase system. The upper phase, which increases
over time, appears clear
and fluid compared to the slightly turbid, gelled lower
phase. This observation indicates
that the enzyme cannot diffuse freely through the gel.
Instead, the gel structure restncts
mobility until the enzyme digests enough sites to destroy
a localized region of the
network. With respect to analyzing HPLC data for determining a
reaction rate, this
observation invalidates the empirical relationship
between [C(t)] and [A(t)] established in
Figure 3.4. One possible model for establishing this
relation in a gel develops from the
premise that the enzyme must digest both sites of
an ATCTA molecule before it can
proceed to another. Following this rigid, static
gel model, [A(t)] = 2*[C(t)] and
subsequent analysis follows the previously
described protocol.
The two models presented for establishing the
necessary empirical relationship
between [C(t)] and [A(t)] represent upper and
lower boundaries for determining reaction
rate. The fluid model, from Figure 3.4,
establishes an upper limit and likely
overestimates the true reaction velocity
because it allows access to all molecules
and sites
equally. The static gel mode, defines a lower
boundary and likely underestimates the true
reaction velocity because it limits access
to sites in the stnctest sense.
The correct model
likely falls somewhere in between as dictated
by dynamic parameters of the gel structure.
Rapid dynamics will approach the fluid
mode, while slow dynamics will approach
the
static ge. mode.. Figure 3.8 compares
the so.ut.on data from Figure 3.7 with
the reaction
rate in a gel as determined by analysis
of data us.ng both the fluid model and
the static
gel model.
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Figure 3.8 Companson of react.on rates
for solutions (.) and gels as
determined by the fluid model () and static model ()
analyses.
The fact that reaction rates measured in
solutions fall between the two values
determined for a gelled sample indicates
that ge, structures do not significantly
inhibit
enzyme activity. Instead, gel structures
limit diffusion thereby limiting the
number of
sues the enzyme can access. An
absolute, accurate measure of
reactton rate in a gel
would requtre a completely revtsed
analytical techn.que that would allow
a direct
measure of [A(t)].
D Conclusions
micmm*— °f^ reac,,ons indica,e ,ha' ,hrombm hydr°'yses
the „ew, y designed series
of ariffleia, proteins eonsisten,
wi«h the mode, proposed in
Eqoa,,o„ 3.1. Proximity of the
active site ,o the neiica, domam does no,
appear to affec,
,he ynetio parameters as
ana„ses of ATC-cys and CTA-cys 8
e„era,e near,, ,de„„c„
M,c„ae„s-Men,e„ piots. Fo~, pro* systems con,ammg two aorive
si.es appear
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to form an enzyme-protein complex as though they contained only one active site. This
interpretation follows from the overlay of Michaelis-Menten plots generated by mapping
reaction rate versus protein concentration for three systems: ATC-cys,
CTA-cys, and
CTATC-cys.
Analysis of the systems of interest, ATCTA-trp and ATCTA-cys, proved more
difficult due to experimental limitations for measuring product formation.
Michaelis-
Menten analyses of these systems required the development of an
empirical relationship
between the measurable product, [C(t)], and the necessary value,
[A(t)]. Mapping
experimental data onto a reasonable model for this empirical relation
generates reaction
rate versus protein concentration profiles for ATCTA-trp and
ATCTA-cys solutions that
overlay Michaelis-Menten plots of ATC-cys, CTA-cys, and
CTATC-cys data.
Analysis of a gelled system required modification of
the empirical model.
Unfortunately, construction of an accurate model would
require a deeper knowledge of
enzyme-protein interactions and the dynamic parameters of gel
structures. Instead, a
second model establishes a lower limit for mapping
experimental data to emp.ncally
determine reaction rate. The model used for mapping
experimental results from solutions
serves as an upper limit for empirically determined
reaction rate. Following these
models, the two empirically determined reaction
rates for a gelled sample fell above and
below the reaction rate of a fluid sample at
equal concentration. This indicates that gel
structure does not significantly inhibit enzyme
activity.
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CHAPTER 4
A STATIC PICTURE OF GEL STRUCTURE
A. Introduction and Objectives
Previous reports by Petka et al. classified ACA protein solutions above 5%
(w/v)
as pH- and temperature-sensitive, revers.ble
hydrogels
'"2
Initial investigations found
loose correlations between pH and temperature dependence
of: a) solution state
molecular structures as measured by circular dichroism
(CD) 3 4 and b) the physical
properties of gels as measured diffusing wave spectroscopy
(DWS) While initial
results from CD and DWS certainly favored hypothetical gel
structures where leucine
zipper interactions dictate crosslink formation,
the evidence remained far from
conclusive. Considenng the ultimate desire to
engineer artificial protein hydrogels for
medical treatments, progress demanded a complete
and accurate description of the gel
structure.
As the title >nd,cates, Chapter 4 describes
the gel structure as a static system while
foreshadowing a dynamic gel structure described
in Chapter 5. Three expenmental
techmques provide the foundation for
elucidating gel structure: CD, analyt.cal
u.tracentnfugat,on, and small angle x-ray
scattering (SAXS). CD and u.tracentnfugation
provide information about dilute solution
behavior of the system in question.
Extrapolate of this behavior to concentrated
solutions serves as a launching point
for
SAXS, which directly investigates the
gel.
,„;„„ solution CD commonly provides evrdence
for the structural changes .ha,
occur ,n leucine ripper proreins as
a function of pH, remperarure,
proiein concentration,
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and denaturant concentration 8
" 16
. Hence, Petka et al. used CD to lay a solid foundation
for future efforts. Work described herein utilizes CD to determine the pH and thermal
melting transitions of an ACA system similar but not identical to the protein that Petka
investigated. Petka reported CD results for an ACA protein containing a cysteine residue
at the C-terminus. The possibility for disulfide bonding complicates structure
characterization as the three-domain system now becomes a mixture of ACA and
disulfide bonded ACAACA proteins. The system described herein circumvents this
problem by investigating an ACA protein containing a tryptophan residue at the C-
terminus, a construct originally designed by Petka ' but not characterized by CD until
recently.
Ultracentrifugation provides information about the equilibrium state of leucine
zipper associations including stoichiometry and equilibrium constants. Unlike other
characterization techniques, ultracentrifugation measures molecular weight without
calibration standards (size exclusion chromatography), structure annihilation (ion
spectroscopy), or extremely difficult data interpretation (viscometry, in the case of self-
associating systems). Instead, ultracentrifugation provides a non-destructive measure of
the system in a natural environment. Furthermore, the scientific literature sets a solid
precedent for interpreting data from self-associating systems
l7 " 25
.
While CD and ultracentrifugation provide evidence for protein structure in dilute
solution, these techniques do not allow investigations at high concentration. In CD
experiments, scattering and absorption hinder the quality of data when concentrations
exceed 10-100 (gelation occurs above 2 mM). Data collection in ultracentrifugation
also presents problems at concentrations necessary for gelation. More importantly, the
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very definition of gels as systems with infinite molecular weight precludes the use of a
technique for molecular weight characterization as a tool for elucidating gel structure.
SAXS, on the other hand, probes the gel structure directly and even benefits from the
higher protein concentration used in sample preparation.
When x-rays scatter from ACA gels, the helical domains should dominate the
observed intensity scattered from gels at low scattering angles for two reasons. First, the
random coil lacks any structure that would scatter at low angles 26
"27
. Second, the helical
domains contain more than twice as many electrons as the random coil domain. Based on
sound literature precedent, Figure 4.1 illustrates some anticipated structures along with
theoretical dimensions for these structures within the gel 28 32 .
Figure 4.1 Theoretical dimensions of possible helical structures.
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These hypothetical d.mens.ons model
the structures as cylinders with
length, L, and
rad.us, r, and serve to d.rect the initial
analys.s of scattenng data as well
as prov.de a
framework for simulated scattering
profiles.
CD, ultracentrifugation, SAXS, and
prev.ously reported data from DWS lay a
solld expenmental foundation for
determining whether the dilute solution
behav.or of
leucine z.ppers extends to high
concentrations in the artificial ACA system. If so,
researchers could engineer artificial
protein hydrogels with phys.cal
propert.es as w.de
rangIng as the leucine z.pper
motif allows. Exciting possibilities
then anse for des.gnmg
gel systems with ta.lored
environmental and phys.ological response.
B. F* perimepta, Methods
B , Pmtrin Biosvn'h"" »"d Purification
Two protetns were studted for determtntng
gel structure: the heltcal
proteiu, A-
trp and the n.u„i-dotn»,n pro* ACA-trp.
Note that each of these protetns
contatus a
C-term,na, tryptophan restdue rather
than cystetne. Protetns were
prepared hy express,™
of the corresponding ar.if.cia,
gene in an K coli host stratu SGB009
contatntng the
.pressor piasmtd pREP4 (Q.agen,
Cnatswodh, CA). Co— of the arttftca, genes
i„ the expression piasmtd
pQE9 (Qtagen) has heeu previous,, reported
'.
The pQE9
expression p,asmid encodes an
KH.ternrina, hexahtsttdtne sconce
that affords protetn
purification hy tmmoh,h.ed meta, affinity
chromatography As „rge-sca,e
h.osynthests
of A-trp and part,cu,ar,y ACA-trp
was he.ng refined dunng the course
o, this worh, the
genera, protoco, ,s reporied
herein wtth enrphasts on the
most successfu, fine detad,
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Small 5 mL cultures were inoculated from
frozen stocks in 2*YT med.a. After
incubation a. 37° C for 5-6 hours. 25 ui.
a,i quo,s were used to
inoenlare larger culrures
(25 mL, !00 r„L, or 1L) in 2xYT
media, which incubated a, 37= C overnight.
Cultures
Were then used, in their entirety, to inoculate
12 L cultures in IxLB med.a. In eases
where a 1 L culture was used for inoculation,
the culture was cen.rifuged and the
cell
pelle. was resuspended in fresh
medta before moculating. A„ media
were supplemented
„» amptcillin (100-200 mg/L) and
k.namycin (25-50 mg/U Once inoculated. 12 L
cultures were tncnbated a,
37" C until opocal deosittes (600 nm,OW reached one. A.
ODtM>l, protetn expresston was
tnduced by the addttton of IPTG (1 mM).
After 4
hours the cel. culture was
sedtmented by cen.nfugat.on a. 150O0 g
for 10 mtnutes. Cells
were then tesuspended ,„ sonteation
buffer (50 mM NaftPO., 300 mM Nad, 10 mM
imidazole, pH 8) and frozen at -20° C.
Protetn punficatton began b, lystng
the cells. Cells were lysed
firs, by thawing,
and then by sonieattng for three,
one-m,nu,e bursts between one-mtnnte
ineubat.on
penods on tee. After een.nfug.6on
for 20 minutes a. 15000g to
remove a„ insoluble
eellular tnatter, ,he supernatant
was collected for purification.
Target proteins were
isola,ed front the supernatant
b, affinity chromatography on
a ntcKelnftnlotnacefie actd
resin (Ni
3+
-NTA. Qtagen) following the nattve
purificafion pro.oeol desenhed in
Chap.er
2 Etaen, solnfions o, pnre
pro.ein were dtalyzed nnder
continuously refreshing D, wa.er
fot 3-4 days .hen lyophiltzed.
Typtca, yields for both A,rp and
ACA-trp expresses
i-. f «,it««. Highest yields were noticed when the 12
L
were 100 ± 20 mg protein per liter of
culture.
cultures were inoculated from 25
mL cultures.
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Further punficatton was
achieved by reverse phase
htgh-pressure h.,:,6
chromatography (HPLC) for prepanng CD
and uttracen.nfugabon sarap.es.
HPLC was
performed on a Waters™ system
compnsed of a 7 17p,ns Autosampie, 486
Tunabte
Absorbance Defeefor, and a 600
Conner ec,u,pped w„h a Nova-Pa**C
phaSe was a .inear gradren,
m.-ture of warer and acetomtnie,
both containing 0.«
TFA.
eoutmued fhroughou, ,hc procedure.
Eiuen, fracrrons of pore protein
were coUected off
the column and freeze-dried.
B 2 Diiuie_So]ytion^
CO samples were prepared from a ,
mg/mL stoct soiution of HPLC pnrrfred
ACA-,rp in P. wafer. Fma, sampie
condrttons were 5 pM pro* iO-
and
CP data were recorded on a ,asco
M15 spectrometer us.ng the
Mowing run
t nt vr flushing Thermal melting
profiles
second response, 20 mdeg sensitivity,
and constant N 2
„ the CD signal at 222 nm([0] 222) as a
function of
were collected by monitoring
the
.emperatureusmga.sco PTC-34SW.
—bead, controUed cuvette huider. Stgna,
was recorded every O.f C as the
temperature was graduady ramped
a, a rate off' C per
^tcBothheatrngandeoohngrampswereruninordertoohserveauyhysteres,,
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Assuming a two state model to describe the equilibrium
between folded and
unfolded states, thermal melting profiles were fit
to Equation 4.1.
(Equation 4.1)
In this equation T is the temperature in Kelvin, 9 is the
CD s.gnal at 222 nm, 9 f and 9 u
are the values of the CD signal for the folded and unfolded
peptide, respectively,
extrapolated linearly to 0 K, and mf and m u are the
respective slopes of the linear
extrapolation \ In a physical sense, the inflection point of the
curve represents the
temperature at which half the leucine zipper domains
are folded and half are unfolded.
B.3. Dilute Solution Analytical
Ultracentrifugation
Samples for ultracentrifugation were prepared
from 10 mg/mL stock solutions of
HPLC purified A-trp and ACA-trp in 200 mM Tns buffer PH 7.4,
and 150 mM NaCl.
Segmentation equilibrium profiles were collected
using a Beckman Optima Senes
Analytical Ultracentrifuge with samples
equilibrated at 20° C and a rotor speed of 22000
r.p.m. (An-60 Ti Analytical Rotor and Cells).
Samples equilibrated for 2-3 days and
equilibrium was venfied by the overlapping of
one profile with another collected ten
hours later. Once equilibrated, 15 scans
were taken and compiled for analysis. The
ultracentnfuge was equipped with XL-I
Integrated Optics and XL-A Absorbance
capabilities for both refractive index (RI)
and ultraviolet (UV) absorbance detection of
concentration gradients. Both detect.on techniques
were utilized. At high concentrations
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(10, 7.5, and 2.5 mg/mL), the measured UV absorbance
was too high, hence Beer's law is
inapplicable, and UV data from these samples were not analyzed.
Ultracentrifugation data were analyzed us.ng
WinNonlin VI. 035 Nonlinear Least
Squares Fit Program For Equilibrium Ultracentrifuge
Analysts
33
.
This program fits data
according to Equations 4.2, 4.3, and 4.4. Table
4. 1 defines the vanables used in these
equations.
Ctoml =SC +±Ku *Cx{r)M
i=l
n
C, (r) = C,,0 * exptcr * (£ - ) "
28 *X Ci <r)]
a--
RT
(Equation 4.2)
(Equation 4.3)
(Equation 4.4)
5C = cone, offset of first data point
o = reduced molecular weight
C,(r) = monomer cone, at radius r
Mi = monomer molecular weight
Cj(r) = i
th
species cone, at radius r v
= partial specific volume
C,,o = monomer cone, at first
data point p = solvent density
q(i) = association state of i
th
species co = rotor speed (rad/s)
B = colligative second virial coefficient
^ = r
2
/2
Ku = equilibrium constant for association
of monomer to q(i)-mer
^0
s r
2/2 at first data point
Table 4.1 Definitions for analytical
ultracentrifugation fitting parameters.
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B.4. Small Angle X-rav Scattering
Gels for SAXS experiments were prepared by dissolving 70
mg ACA-trp in ImL
buffer (100 mM Tns, 100 mM AMP, pH not adjusted pnor to
protein dissolution). Upon
dl ssolution of protein, a PH of 4.9 was measured. An 8
N NaOH solution was added
incrementally to adjust pH. Initially, 5 pL
increments were added and gradually reduced
to 1 uL increments as sample aliquots were
removed. Several aliquots were transferred
to 1 mm quartz capillaries (Charles Suppan
Co.) at each pH: 4.9, 6.5, 7.2, 7.6, 7.9, 8.3,
8.8, 9.4, and 12+ . For each pH, two
scattering profiles were collected:
non-annealed
samples (still fluid) and samples annealed
at 80° C for 2 minutes then quenched to room
temperature (gels). Temperature dependent
scattering profiles were also taken for
six
annealed samples (pH 4.9, 6.5, 7.2, 8.3, 9.4, and
12+). Samples were heated from 25°
C
to 80° C at a rate of 2° C per minute using
a Linkam THMS 600 hot stage mounted in the
beam controlled by a TMS 93 temperature controller.
Temperature dependent data were
collected at one exposure per minute.
SAXS experiment, were performed on the
h.gh brilliance undulator beam line
(DM2, BESSRC-CAT) at the Advaneed Photon
Source (APS), Argonne National
Laboratory ». Scattered x-rays were
detected using a 15 cm x 15 cm,
9-segment, 2-
drmenstonal CCD Gold detector. Three sample to
detector dtstances (4 m, 2 m, and 1 m,
were used with beam energ.es of 12 xeV
and 10 IceV. These instrument
conftgurahons
a,l„„ed the exp.oratton of c-space from
about 0.005 A ' to 0.7 A". Data was eomected
for dark current, masked, and
az.muthally averaged using programs
provided a. the APS,
Background scat.enng profiles were
collected from buffer solutions and
treated
identically. Background scat.enng was
subtracted from expenmental da.a in
1-
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software.
would not affect the results.
B5 CorneuMMou^^
^.^.au.e^of^o^o,— «'
thcore„ca,seat,en„g
ptof, 1ewaS ca,cu,a«e,
aceorf,u g ,oEuua„„u4,
;
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1 ^ V ^"Wsin(<?* ri/) (Equation 4.5)
N 2
,
,
In this equat.cn, q represents the
magnitude of the scattering vector and ry
represents the
distance between the i
th
and j
th
scatterers.
Theoretical scattenng profiles from helical
bundles were simulated based on the
hypothetical dimensions found in Figure
4.1. Most simulations were run with
R,^0A,
although one tetramer bundle simulation
was run With R, = 5 A. The number of
po.nt
scatterers (N) was set proportional to the
number of electrons in each particular
bundle.
would require an unreasonable amount
of time. Instead, N was set such that each
bond
and each atom were treated as point
scatterers.
C. Results and Discussion
The task of elucidating gel structure
began with dilute solutron CD of ACA-cys as
reported by Petlta „ a, Subsequen, to
this work, efforts shifted to the
ACA-rp system ,
aTO1d potential difficulties ansing
from the effects of disuif.de bondmg a,
the Cernunus.
Figure 4.2 compares the thermal
melting of ACA-trp with data
reported by Petk, for
more hysteresrs (5" C a. most, except for
the very unsrable PH 12 sample, compared
to
ACA-cys (T C, no, included in the graph).
Different thermal h.stones hkely
contribute
t„ this drscrepancy; i.e. Petlca
subjected samples to a thermal cycle
before measurement.
More important,,. ACA-,rp
demonstrates a slightly lower melting
transrtion than ACA-
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cys between pH 7 and pH 9.5. This observation comes as no
surpnse considering a
report by Hodges et al.
'°
that an S-S link at the N-terminus of a 43-residue
tropomysin
analog stabilizes the association and shifts the
melting transition 6.5° C higher. Neither
ACA-trp nor ACA-cys exhibit measurable thermal
transitions below pH 6.
u
Figure 4.2
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r
70
50
30
10
• ACA-trp (T° increase)
ACA-trp (T° decrease)
ACA-cys (Petka e/ a/.
1
)
9 10
pH
Thermal melting trans.t.ons for ACA-trp (5
pM), measured by CD
with increasing (•) and decreasing () temperature, and
ACA-cys
(5 pM) reported by Petka et al. ().
Because the ACA-trp data does not demonstrate
any unusual trends with respect to data
reported by Petka, the present argument only
presents a brief synopsis of previous
interpretation.
Petka first reported thermal melting
transitions for two different leucine zippers,
one with primarily acidic amino acids in
the e and g positions of the z.pper
(Al) and the
other w,th primarily basic res.dues
at those positions (B 1). This work
demonstrated that
Al-Al, Bl-Bl, and Al-Bl interactions
display unique thermal behavior at
different pH.
88
Furthermore, th.s work established that the thermal melting
of Al-Al interactions
naturally controls the thermal behavior of the ACA-cys
system in dilute solution. With
the evidence of Figure 4.2, a reasonable argument
follows that Al-Al interactions also
control the thermal behavior of ACA-trp in dilute
solution. Hence, if coiled-coil
structures in concentrated gels and dilute solutions
exhibit similar pH and thermal
dependence, the evidence for molecular control of
macroscopic physical properties
strengthens.
While CD verifies the existence of temperature and pH dependent
structures in
dilute solution, the experiments provide no
information pertaining to the association state
of the helical domain in question. Analytical
ultracentnfugation answers this question.
As evidenced by the complexity of Equations 4.2,
4.3, and 4.4, analytical
ultracentnfugation affords a wealth of information
about self-associating systems. In
keeping with the goal of elucidating structure,
expenments and subsequent analyses
targeted the equilibrium association state
of the helical protein A-trp and the mult,-
domain ACA-trp.
Two general methods for fitting data indicate
that the Al leucine zipper motif
found in A-trp and ACA-trp self-associates
as a tetramenc helical bundle.
Figure 4.3
summarizes the results of one fitting method
that determines the apparent molecular
• wetght of the system independent of any
assumpttons. This method requires fixing the
equihbnum constants (K„) effectively at zero thereby
calculating the best fit as though
the system were non-associating.
Depending on the detection system used, the
apparent
MW from the fit gives either a weight average (from UV data)
or z-average (from RI
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data) molecular weight. (See Appendix A for a mathematical explanation of MW
distribution moments as they pertain to analytical ultracentrifugation).
35 . , , , , , i—. - ' ' ' ' •
« Q
O M
g ^
J-. (L)
<
Figure 4.3
z-average
• z-average
weight-average
Tetramer-
30
25 !
Trimer
0.1
[A-trp] (mg/mL)
Summary of analytical ultracentrifugation for A-trp. Both RI (•)
and UV () detection techniques utilized. The highest
concentration data () fit poorly to the model used.
The investigated concentration range required using both detection
techniques hence both
weight and z-average molecular weights appear in Figure
4.3.
Figure 4.3 proves that A-trp self-associates in bundles
larger than three helices per
bundle because the average molecular weight is larger
than a trimer bundle in all cases.
If leucine zipper monomers (M) associate to form n-mer
bundles (M„), Equations 4.6 and
4.7 describe equilibrium in the system:
kl (Equation 4.6)
nM : * M„
M. - K - ^
M
'^ (Equation 4.7)
k2~ U [M]"
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As monomer concentration increases, the concentration of helical bundles increases
proportionally to the n
th power, provided the association behaves ideally. Therefore,
weight and z-averaged apparent molecular weights, as measured by ultracentrifugation,
will asymptotically approach the molecular weight of the equilibrium
association state as
monomer concentration increases. The data in Figure 4.3 appear to approach the
expected molecular weight of a tetramer, although the highest concentration data
remain
suspect. Residuals of the high concentration fits indicate non-ideal
associative behavior.
This observation may reflect less specific interactions that eventually cause
precipitation,
thereby explaining the non-asymptotic approach towards the theoretical
tetramer
molecular weight. Thus, the data in Figure 4.3 strongly suggest
that A-trp self-associates
as tetrameric helical bundles.
Another general method for fitting the data also supports equilibrium
tetramer
structures. The method involves fixing all but one of the equilibrium
parameters at zero
(i.e. Ki i = 0 for i = 1, 2, 3, and >5) while floating the
remaining equilibrium parameter
(i.e. KM) and the reduced molecular weight (a). Only two cases of
this method resulted
in good fits with sensible residuals: floating K,, 2 , and
floating K,,4 . Floating Ku resulted
in an apparent monomer molecular weight twice
the expected molecular weight of A-trp.
In other words, K,,2 actually represents dimer-tetramer
equilibrium. Floating K,,4
resulted in an apparent monomer molecular weight
nearly to that of A-trp. Figure 4.4
summanzes results from these two fitting schemes for all
concentrations.
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9.5
7
S Q
O 0)
7.5
0.1
[A-trp] (mg/mL)
Figure 4 4 Summary of analytical
ultracentrifugation for A-trp. Two fitting
8
schemes!floating; KM (•) and K,2 (), are represented
along with
the expected molecular weight of A-trp (
)•
Attempts to fit the data while simultaneously
floating K„ and KM resulted in
program errors with the fits approaching
Ku = 0 and KM equal to the value
obtained
from fit descnbed above. All
observations indicate a three state system
where
monomers, dimers, and tetramers maintain
equil.bnum until concentrations become too
hlgh and precipitation begins to occur.
At the concentrations investigated,
tetramer
bundles dominate the equilibrium to the
point where monomer-dimer equil.bnum
cannot
be measured. Revisiting Equations
4.6 and 4.7 with a three state
equilibnum in mind
.suits in a more descriptive model for
equilibnum presented in Equations 4.8, 4.9,
4. 10
and 4.11:
M 4
kl/ \k4 (Equation 4.8)
7k2k5k3\
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kl/k2 = dimer-tetramer equilibrium
constant.
k3/k4 = monomer-tetramer equilibrium
constant.
k5/k6 = monomer-dimer equilibrium
constant.
(Equation 4.9)
(Equation 4.10)
(Equation 4.1 1)
AM told, analytical ultracentnfuga.ion
data provtde sound evidence fo, the
presence of tetramer heiica,
bundles in the A-.rp protein system.
Furthermore, if tnts
behave, extrapolates ftrst ,„ ACA-trp
soluttons, then to concentrated gels;
tetramene
species should dominate the gel
structure.
As memtoned previously, the very
nature of the ACA-trp system
excludes the use
4 analytical ultracentnfugatton for accurate
structure determtnatton. Because
each
macule has two hehea, dom.tns, man,
poss,b„,t,es atise for larger
structures, even in
S6S soiution. Unlike theW system, the apparent molecular weigh, of an ACA-trp
solu,,„„ wif, conttnuously
tncrease as eoncentratton
increases, never approachmg an
asymptotic limit Therefore, the
methodtca. eoncentratton
dependent expeoments
performed on the A-trp system
provtde no fonndatton fo,
eluctdating the etunhbnum
slate of ACA-trp because
concentration alters equilibrium.
Ftgure 4.5 illustrates a
hypothettea, progress,™ of
structures formed as eoncentratton
increases.
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Figure 4.5 Hypothetical
progress.on of ACA-.rp structures.
A s,„ g,e ul.racen.nfuga.ion
expenmen. on the ACA-trp sys.em (,
rug/ntL, suggests that
lhe dilute solution structure
of ACA-trp resents the firs,
tilustrated species ,n Figure
4 5 Frgure 4.6 presents the
data from .his expenmen.. along
with the resrduals from a fi,
run with equ.lihrium eoustants
fixed a, zero. The apparent molecular
weight of 39576 Da
nMrl, tiouhles the molecular we.gh,
of a smgle ACA-trp molecule (22091
Da,. A fitting
scheme that floats K„ also results ,u a reasouahle
fit of the data aud yields a
monomer
molecular wergh. of .9684 Da. .u
th.s case. K,, truly represents
mouomer-dimer
equilibrium.
A„a,ytical ulfracentrifuganon of
A-,rp and ACA-trp provide
sound evidence that
,„e Al leucine zrpper domam estahhshes
an equ.„h„um tendmg
towards tetramer hel.ca,
oundles as concentration
Increases. Hypothetical!,,
tins hehav.or exfiapolates
to the h,gh
concentrations used m ACA-trp ge,
preparations, ultimately leading
to the formation of
ne.wora s.ruc.ures.
Unfortuua.e!,, the suspect
data a, h.gh concentrations
in the A-trp
sys,em and .he complex,., of
s.ruc.ures poss.hle in .he
ACA,rp system render
„„racen.„fuga.,on .nadequa,e for
prohiug ge, s.ruc.ures directly.
For dtrec,
investigations, efforts shift to
SAXS.
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0.05
-0.05
<
25.5
Figure 4.6 Analytical ultracentnfuge
data (UV) for 1 mg/mL bottom
plot) and reS1duals from a fixed
equ.libnum fit (ft P plot),
indicates a weight average molecular
weight of 39576 Da.
Analysis of SAXS data initially approaches the
system by modeling helical
bundles as cylindrical scatterer,
Several x-ray diffraction studies
from the leucine zipper
Literature support this first
approximation and provide guidance for
SAXS analysis
Equation 4. 12 completely descnbes
the amplitude scattered from a
cylinder with cross-
35
section A and length L .
^ 2
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In this equation and other scattenng equations
to follow: Ap represents the difference in
electron density between the cylinder and the
surrounding medium, q represents the
scattenng vector, y represents the cosine of
the angle between q and the cylinder axis,
and r
c
represents the radial vector in the plane of the
cylinder cross section. Terms inside
the integral represent contnbutions to scattenng
from the cross-section of the cylinder.
Factors outside the integral represent
scattenng contnbutions from the axial
component.
The total scattered intensity from this system
equals the square of F,(q) averaged over all
onentations. Unfortunately, the exact
solution to this ensemble average remains
unsolved, so any general solution requires
certain approximations.
One approximation, applicable to all particle
scatterers, stipulates that q < (1/Rg),
where Rg represents the radius
of gyration, or the mean square
distance from the center of
gravity of the particle. In the case of
cylinders, a srniple geometnc analysis
defines the
relattonship between Rg, Re, and L shown in
Equation 4. 13. Rc represents the radius of
gyration of the cross-section.
_ ]} (Equation 4.13)
Provided that q < (1/Rg), Equation
4.14, the general Guinier
approximation, holds for all
symmetnc particle scatterers independent
of shape.
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-q 2 R 2
I(q)~(Ap) 2 *V 2 *exp(^-^) (Equation 4.14)
A Guinier analysis of scattering data involves plotting ln[I(q)] vs. q
2
. A linear fit of low
q data provides critical information about the radius of gyration of a particle scatterer 3S
.
Figure 4.7 illustrates a representative Guinier analysis of scattering from ACA-trp
gels. For comparison, the figure includes the expected Rg of a tetramer helical bundle
calculated using Equation 4.13 and the dimensions given in Figure 4.1.
q
2
(A"
2
)
Figure 4.7 SAXS from a 7% (w/v) ACA-trp gel (pH 7.6, 25° C, after annealing),
representative plot for Guinier analyses of gels.
The upturn in the lowest q region arises from the presence of even larger structures,
consistent with the idea of a network.
Figure 4.8 summarizes the affect of pH on Rg , as determined by Guinier analysis
of the pH sample series. Near physiological pH, the data appear unaffected by annealing
and consistent with the expected Rg of a tetramer. Unfortunately, Guinier analysis does
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not prov,de information concerning
the primary parameter of interest in a cylindrical
system, R„ because contributions from the
length dominate the calculatlon of Rg .
Consider two systems: a d.mer with L
= 65 A. K = 6.6 A, and a tetramer with L = 64 A,
Rc = 9.6 A. The calculated Rg for these
two systems differs by less than 1 A,
suggesting
Jat L must be known exactly, and Rg must
be measured accurately « 1%) to have any
hope of determining R c from a Guinier
analys.s alone. "Presently unattainable"
best
descnbes the possibility of meeting
these stnngent stipulations. Given the
sound
Hterature precedent that L = 65 A, a
complete picture of gel structure demands
an
independent and accurate measure of R,
Independently measunng Rc requires analys.s
of data at higher q where the Guinier
approx.mat.on breaks down.
Before anneal
• After anneal40-
30
20
pH
Expected for
tetramer
Flgure 4, S« of Gu;„,e, -yses of 7, (wM ACA-.rp before <> and
after (•) a two minute anneal
at 80 C.
A commo„ appro>,n,a,,o„ for cyl
i„dnca, sys.cns a, h.gher ,
quires «ha, L»d,
98
components of the system effectively scatter
independently. As such, Equation 4. 12
conveniently sptits into two separate
equations, each averaged independently over
all
onentations. The two solutions combine to
give an approximate Equation (4.15) for
the
scattered intensity from a cylinder.
n ? T ,2 , r q Rc \ (Equation 4.15)
/(4) = -(AA) 2 *L*A *eXp(—
—
-) ^ 4
i
As with the Guinier approbation,
Equation 4. 1 5 holds only over a g,ven
range
of q-space. The axial component of
scattering reduces to rt/q only when q > (L/U Also,
the cross-sectional component
reduces to e*p(-qV«) only when q <W Data
analysis based on Equation 4.15
follows with a sUght modification
of the Guinier
analysis. Rather than an ordinate
of ,n[l(q)]. the modtfied analysts
plots Mr** vs. q!
Multiplication of the scattered intensity
by q removes the 1/q dependence
contributed
from the axia, dtmenston of the
cyltnder. Though based on the posstbly
mcorrec,
premise tha, L»d, this modified Gutnier
analysts gutdes the subsequent
analyses of
SAXS data.
Flg„,e 4.9 tllustrates a
representative modtfied Guinter
analysts of scattenng from
ACA-rp gels. For companson, the
figure mcludes the expected Rc
of a te.ramer heltca,
bu„d,e calculated using the
dtmenstons given in Ftgure 4.,.
As with the genera, Gum.er
remonstrates a local intensity
maxtmum. Dtfferenttattug a
more precise approbation
,„ place of Equation 4.15. the
two cylindncal parameters L
and Re define the position
of
the maximum (q*) observed in Figure 4.9. Fixing these parameters at the expected
values for a tetramer bundle (L = 65 A and R c = 9.6 A) results in a calculated value of q<
that reasonably agrees with the observed value. However, the suspect approximation
(again, L»d) used for this calculation excludes this observation from any compelling
argument for the presence of tetramer bundles.
-10.0
-10.2
-10.4
-10.6
-10.8
Modified Guinier analysis for rodlike forms:
R c = 8.3 A (9.6 A expected for tetramer)
q*Rc = 1.0065
0.015
q
2 (A 2 )
Figure 4.9 SAXS from a 7% (w/v) ACA-trp gel (pH 7.6, 25° C, after
annealing), representative plot for modified Guinier analyses of
gels.
Also, the difference between measured and calculated values of Rc seen in Figure 4.9
raises questions concerning either 1) the assumption of a tetrameric state or 2) the validity
of the model, i.e. Equation 4.15.
First, the assumption of tetramer bundles appears incorrect because the measured
Rc actually equals the expected Rc for trimer bundles. This observation directly
contradicts analytical ultracentrifugation and protein precipitation at high concentrations.
These indicate that high concentrations drive equilibrium towards bundles of 4 and any
deviations tend towards higher aggregation states. Without completely dismissing this
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possibility, attention should shift to the possibility that the
model for fitting x-ray data
(Equation 4.15) does not accurately depict the system in question.
Again, Equation 4.15 rests on suspect approximations concerning
aspect ratio and
q-space. This necessitates an alternative model for comparison;
computer simulations
provide one such alternative. Initial simulations validated
the computer model using
parameters that satisfy the assumption L»d. Such input parameters
resulted in perfect
agreement between the input parameters that define Rc and the value
determined by a
modified Guinier analysis of simulated data. Figure 4.10
illustrates modified Guinier
analyses of simulated scattering from model dimer,
tnmer, and tetramer systems with the
dimensmns from Figure 4.1 as input parameters. The
profiles in Figure 4.10 exhibit
.dentical features to profiles both simulated and
predicted from less stringent models
where L»d. This suggests the modified Guinier analysis
still applies, although the
considerable differences between measured and
expected values of R c indicate that the
analysis underestimates the cross-sect.onal
radius of gyration when the condition, L»d,
is not met. Compared with the tetramer
simulation analys.s of Figure 4.10, the
experimental data presented in Frgure 4.9 now
favors a tetramenc helical bundle
interpretation.
-3.1
-3.3
R-c dimer - 5.3 A (6.6 A expected)
7.9 A (9.6 A expected)
0.001 0.005 0.010
q
2 (A2 )
0.015
Figure 4.10 Modified Guinier analyses of simulated scattering data for dimer
( ), trimer (••••), and tetramer (• — •— •) helical bundles.
Before committing to this interpretation, a slight modification of the tetramer
model requires consideration. Figure 4.1 1 compares experimental data (from Figure 4.9)
with data simulated from a tetramer model that includes a 1 A pore.
-10.2
0.005
q
2 (A 2 )
0.015
Figure 4.1 1 Modified Guinier analyses of experimental data (•) from a 7%
(w/v) ACA-trp gel (pH 7.6, 25° C, after annealing), and simulated
data ( ) from a tetramer model with a 1 A pore.
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Literature reports utilizing x-ray diffraction to construct atom-by-atom blueprints of
leucine zipper structures claim that tetramer helical bundles exhibit an
electron-free, 1 A
pore along the central axis of the bundle
32
.
The pore forms because the packing
arrangement of hydrophobic residues geometrically prohibits complete
space filling
within the bundle.
The agreement between experimental and simulated data demonstrated
in Figure
4.1 1 strengthens the hypothesis that tetramer helical bundles
exist within the gel
structure. Figure 4.12 summarizes the affect of pH on Rc , as determined by
modified
Guinier analysis of the pH sample series. Near physiological pH, Rc
appears unaffected
by annealing and consistent with the expected Rc of a tetramer as
predicted by analysis of
computer simulations.
20
Before anneal
After anneal
Simulated prediction
for tetramer bundles
f
1210
pH
F,gure 4. 12 Summary of modified Guinier
analyses of 7%W ACA-trp
before () and after (•) a two minute anneal at 80 L.
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Error bars at PH 4.9 and 6.5 in Figure 4.
12 do not solely represent deviat.ons between
runs as for points at higher PH.
Rather, these large error bars indicate
deviations both
between runs and within a given run.
At low PH, modified Gu,n,er
analysis resu.ted in
profiles with two distinct linear
regions. An averaging of these two slopes,
followed by
an averaging of runs generates the
error bars reported above.
Utilizing as input parameters the
expenmentally measured values of Rg and Rc ,
length. As expected, Figure 4.13
nearly overlaps the summary of Rg
presented m Figure
4.8 With proper scaling of the
ordinate. In following with Rg , the results
near neutral PH
demonstrate lengths in accordance
with theoretical predictions.
140
100
60
Before anneal
• After anneal
Expected
for helix
|H t
PH
minute anneal at 80° C.
104
Considering the agreement on all fronts between experimental data and simulated
data based on soundly precedented input parameters, the presence of tetramer helical
bundles in gels near physiological pH seems unquestionable. Furthermore, deviations
from these expected structures at high pH and low pH agree with previous experimental
observations. At high pH, CD indicates that nearly 100% of helical structures have
unfolded at 25° C, hence the dramatic reductions in Rg , Rc , and L. At low pH, several
experimental observations suggest that the helical bundles form larger aggregates that
may eventually lead to precipitation. First, CD reveals a stabilization of helical
structures, as nearly 100% of helical structures remain at pH 5.35 and a temperature as
high as 90° C. Second, analytical ultracentrifugation suggests non-ideal helical
associations occur at very high concentrations, even at physiological pH. Finally,
extended annealing of samples does lead to precipitation, especially at low pH.
Data presented thus far establishes that tetramer bundles exist in the gel structure
and that these bundles exhibit similar pH dependence to those in dilute solution.
Evidence that the helical bundles within the gel structure also exhibit similar temperature
dependence to those in dilute solution would further validate the hypothesis that the
molecular design of leucine zipper domains controls the macroscopic properties of the
gel. Temperature dependent SAXS provides this evidence. Figure 4.14 shows the
temperature dependence of Rc for five samples at different pH. Although the data at pH
7.2 appears to follow trends exhibited at other pH, previous experience with beam
damaged samples raises concerns about the pH 7.2 data. Typically, beam damage causes
proteins to aggregate giving rise to an increase in Rg and Rc . The steady increase in Rc up
to -60° C likely indicates that the sample slowly experienced a minor amount of beam
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damage. Considering the downturn above -60° C consistent with the pH 8.3 and 9.4
samples, very little evidence exists suggesting the observed increase in Rc represents a
real effect.
°<
1 1 r
:
A,
pH 6.5
pH 7.2
|pH8.3
% pH 9.4
't
pH 12+
30 40 50 60 70 80
T (°C)
Figure 4. 14 Temperature dependence of Rc for 7% (w/v) ACA-trp samples
with pH 6.5 (A), 7.2 (•), 8.3 (), 9.4 (), and 12 (T).
At each pH, the SAXS measured onset of structural changes demonstrated in
Figure 4.14 occurs at a higher temperature than the thermal unfolding transitions reported
in Figure 4.2. One possible explanation for this discrepancy arises from the subtle
differences in structural information provided by the two experimental techniques.
Circular dichroism measures total helical content of the system as a function of
temperature. Normalization of raw data between the extrapolated limits of 0 f and 6U (as
defined for Equation 4.1) results in a plot like that shown in Figure 4.15.
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3T(°C)
Flgure 415 cd d»
-ttrrwSttttZZ
Hots of Ms type prov.de a reasonaMy
accurate defin.t.on of T. -* •
'hC
fiact.on unfolded ec,„als 0.5.
Therefore, approx.mately M/of the helical structures
remain at the thermal unfolding
transition, as defined by CD.
SAXS, on the other hand, coilects
a fime-averaged measurement
of «.« structures
present. A. ,o„ „, nnfoided
pro.e.ns scatter x-rays a,
much iower tntenstties(W than
tetramer bundies(W As a result, measurements of fc from m„d„,ed Center
analyses of low , data remain
essentially unchan ged as structures
unfold because only the
number (N) o, scatterers decreases,
not their shape. Only when the
ratio N»a
„
/
K. the temperature
dependence of scattered intenstty
should prov.de a better
companson
t0 CD data. F,gure 4,6 dentons.rates
ho* the scattered intensity
decreases »,.h
ir.creas.ng temperature whfie
the slope of the linear
regime (hence„ rema.es
relatively
unchanged.
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temperatures of 27 t
80" C ().
cays and CD data would follow from a plot of
A more accurate comparison
between SAXS
peak intensity versus temperature
as shown in Frgure 4.17.
Notice that the SAXS expenment
d,d no, reach a complete,,
unfolded state as
,dica«edc,,he ahsenceof
asymptotic mtmma. As a result.the
SAXS data were
„„r
ma,„edhe.ween,hepeak
,n,e„si„esa„helowes,andh,E
hes„empera,urese>p,ored.
As such the SAXS data presented
in BEure 4. 17 underesumate
the thermal transrtton
be,wee„ heltca, structures
andno structure. Even so.HB
ure4. 17c,ear,ydemo„s,ra,es
,h„as,g
n,r,can,frae,.o„ofhehca,s,mcturesrema,ns,n g
e 1s at temperatures
ahove 50-
Candtha, a, leasthalf of the
structures remam even
a, 65" C. On the other hand,
CD
_,ha, less than nalfofhehca, structures remam ,n drlute
solutton at tempemtures
above 50° C.
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T(°C)
Flgure 4.17 Companson of
CD and SAXS temperature dependence
for a
sample at pH 8.3.
Th.s discrepancy likely
from .he effects of concen.ra.ion
on leucine z.pper
to,T„ .ncreases between XT
C and 21° C wnen co„cen,ra,,on
.ncreases fro™ 35 pM to
, mM - Likewise, Bossnard e, a,, repod
for a s.m.larsy-M T. ceases ,8" C
1 ? „M to 0 378 mM 37 . As points for comparison:
when concentration increases from
12 u .3 nu
, o j /ji < describe a 5 uM ACA-trp solution and
SAXS
CD data reported in Figures 4.2 and 4.15
cn n
da.arepoded 1nHgUreS 4,6 and4.nde
Scnbea3 mM ACA,n> gaO,e„.h
e,„era.„re
A fmal pen, ,ha, na.nrally
follows from .Ms las. ooser.apon
raises *.—«
* defines ,„e ge, s„„c.ure as differen. from solnnon S—
Analytical
rcspec,,ve,y.CD a„dSAXS,nd,ca,s,r„.lar.
herm^ehav,orof.hese,eUc,„=,Pper
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interactions in solutions and gels. What differentiates solution
from gel? Chapter 5
attempts to answer this question by investigating the
dynamics of strand exchange
between helical bundles and how this dynamic process
relates to tetramer equilibrium,
thermal unfolding, and macroscopic physical
properties.
D. Conclusions
Results from circular dichroism, analytical
ultracentrifugation, and small angle x-
ray scattenng all point to the ACA-trp network
structure consisting of leucine zipper
tetramer bundles acting as physical crosslinks.
Near physiological pH. the helical
bundles appear stable in their equilibrium
tetramenc state, even though the helical
domains themselves would precipitate at the
concentrations necessary for gelation.
Apparently, the water soluble, random coil domain
prevents the helical bundles from
precipitating. Even so, the helical bundles
exhibit similar structural thermal
dependence
in the gel as in dilute solutions.
This important observation provides a
foundation for
engineenng the macroscopic physical
properties of artificial protein hydrogels
through
precisely controlled molecular interactions.
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CHAPTER 5
FUTURE DIRECTIONS: CONTROLLED DYNAMIC
STRUCTURE AND
UlKb
unjqufly ACTIVE HYDROGELS
A. Introduction and Objectives
Exper.men.al results reported in Chapter
4 strongly support a network
s.ructure
composed of .etramer hencal bund,es ac.mg
as physical crossl.nks. These results
a,so
indicate, albe,. weakly, a dynamic
network structure where phys.ca,
crossi.nks
continuously unfold and refold.
Macroscop.eally. .he ensemble average of
this
continuous unfolding and refolding
defines the ec,u.„bnum (static)
ne.work structure
descnbed ,„ Chapter 4. However,
the dynam.c parameters of strand
exchange between
hehca, bund.es w„l undoubtedly
control maeroscop.c physical
properties such as elasfie
modulus, ineiasfie modums, stress
reiaxation. and diffusion. Coupled
with an expanding
knowledge of mo.ecular dynamics in
ieueine zipper systems » the
b,osyn,he.ic
technics described in Chapier 2 could
prov.de a means to control strand
exchange
oynamic, Hence, a nex. step in
developing art.fic.a, pro.ei„
hydrogel systems retires a
trough unders.and.ng of .he corre.anon
between molecula, dynamics and
maeroscop.c
physical properties.
Chapter 5 presents a scatter of
preliminary expertmenta, results
support.ng.he
hypothesis «ha. molecular
dynam.es and macroscopic
phys.eal propert.es conela.e.
Two
fluorescent .eehmflues, fluorescence
resonance energy .ransfer
(FRET) »
and
fluorescence recovery after
pahenred phcohieach.ng (FRAPP)
-« pmv.de a ghmpse of
Spec.roscopy <DWS,
« eomp,eme„.s FRET and FRAPP by prov.d.ng a means
to
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explore maeroscopic phys.cal properties
on the mrlliseeond and mtcroseeoud time
scales
tha, overlap leucine ztpper
molecular dynamtes. Ltm.red instrument
rime prevented these
experiments from develop.ng into stgntfiean.
investigations. Nonetheless, quickly
„b,a,„ed results from unrefined experiments
demonstrate exei.ing trends thereby laying
a
foundation for future efforts.
B. F.x peri mental Methods
ACA-trp and ACA-cys pro.etns were
prepared following the proeedures
for large-
seale biosynrhesis and purification
desenbed in Chapters 3 and 4.
B P t .helinp Protein "i'
h vxommm Probes
Two maletmide funetionaltzed fluorophores,
fl„oresce,n-5-ma,eimide and N ,7
dimethy.am,no^me,hy,eouma„n-3-,l,ma,e,m,de
(Molecular Probes, Me.), were used to
,abe. .he ACA-eys protetn. The
maletmide group reaers w„h the thiol
present in rhe C-
protein in 10- Na.HPO. pH 5.5),
TCEP (50 mM in phosphate buffer pH 5,5),
and
fiuorophore (100 mM ,n DMSO) were prepared.
New fiuorophore stock solutions
were
prepared tmmediatel, before use.
TCEP stock was added to ACA-eys
stock so that
reaction mtxtnres had a rafio of
5 moles TCEP to i mole ACA-eys.
Afier a penod of 10
mi „u,es, fiuorophore shock
was added to the reaction
mixtures so that the final molar
ntio of fiuorophore ,o ACA-cys
was 20: 1 . Reaetton
mtxtures were mcubated a, room
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4 for MALDI-TOF enarae.enzauon
and UV-vi sibfe Ugh. action ,0 onanpfv .he
extent of labeling.
B2 FluoieicenceRejonanc^
Sroek scions of ACA-eoumann and
ACA-.rp (.0 pM> were prepared ,n
onffer
(1M mM Tr,S , ,00 mM AMP, pH 7.4,.
AUonors were removed and pH
was ad.os.ed
„ si „gNaOHorHCUopreparea S
eneS „tSamp 1eso,Ul,o„S w,lh
pH,0.pHS.,a»dpH
, u „h were then mixed under the following
10 0 Sample solutions with
the same pH
condltions: 50,L ACA-coumann, 50,
L ACA-trp,and 900,L ddH2O.
Immediate,
dnve, Samples Were excited
at 281 nm and the emitted
^orescent intensi, at 342 nm
pr* software Fluorescent intensity data
was collected at a rate
of 5
was recorded using Felix
re, nuoi
, pr S400 3600 and 600 seconds
for pH 7.0, PH 8.5, and pH 10.0
points per second ove
5 U, iow, <*
samples, respectively.
B3 FUKKe^^^
f ACA trp (70 mg/mL) and trace
amount of ACA-fluoresce,n
A 1 mL solution o CA-tr
\iv &
(<lm^) w,prepared,n tafferO00
mMTnS , 100 mMAMP,pH7.,and
lhepH
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Axiovert 100 inverted microscope equipped with a Zeiss LSM 510 Laser Scanmng
Module. Using a lOx objective, the microscope was configured
to scan a 250 urn x 250
urn area of the sample at full laser power for 5 minutes,
thereby bleaching the viewed
area. After 5 minutes, the microscope configuration was
adjusted to scan the surrounding
1 mm x 1 mm area at 10% laser power. Images were collected
at a rate of one every 5
minutes over a period of 75 minutes. Intensity profiles
were then generated across a
section of the image. Profiles were normalized between
zero and one, zero being the zero
intensity limit of the microscope, and one being the
average intensity outside the
bleached area.
B.4. DiffusingWave Spectroscopy
A stock solution of ACA-trp (140 mg/mL) was prepared
in buffer (100 mM Tris,
100 mM AMP) and the PH was adjusted to 7.3 using NaOH. Aliquots
were removed and
the pH of the stock solution was adjusted using NaOH
to approximately 13, as measured
by PH paper. Again, altquots were
removed. Sample aliquots were then mixed
with
equal volumes of polystyrene microsphere
suspensions (Duke Scientific) resulting in the
following array of samples, all with 70
mg/mL ACA-trp: 400 nm PS particles pH 7.3,
800 nm PS particles pH 7.3, 400 nm PS particles
pH -13, 800 nm PS particles pH -13.
A second aliquot of the 800 nm PS particles
pH -13 sample was treated with HC1 to
lower the PH to -9.5, as measured by PH
paper. Samples were transferred to 45 mm x
10
mm x 1 mm rectangular glass cuvettes,
annealed at 70° C for 3 minutes, then quenched
to
room temperature.
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Dynamic intensity autocorrelation functions of light scattered by PS tracer
particles in gel samples were measured using a Coherent Innova 300 Ar
+
Laser source
operating at 514 nm in transmission geometry, two Hamamatsu photon counting units,
and a Flexible Instruments dual-photon correlator card along with supporting software.
Unsolved electrical problems limited use of the correlator to single-photon mode. Even
in single photon mode, electrical problems limited the time for data collection. For pH
7.3 and pH -9.5 samples, data were collected over two hours. Longer collection times
(10 hours) were run overnight, but were often not interpretable due to intense,
arbitrary
frequency spikes that overwhelmed the autocorrelation function. Frequency spikes were
also observed in a few of the two-hour experiments. Results reported herein
represent ai
average of at least three meaningful, two- hour experiments. Samples at pH 13 required
only 5 minutes for an accurate measure of the autocorrelation function.
C. Results and Discussion
As evidenced by the general reaction protocol described in the
experimental
section, fluorescent labeling reaction conditions, purification
techniques, and subsequent
characterization still require one or two reiterations for
optimization. The quality of
MALDI-TOF spectra and UV-visible light absorbance measurements continued
to
improve as lab techniques were honed. At the time of this
writing, MALDI-TOF spectra
demonstrated a single, broad peak near the expected molecular
mass of a labeled protein
and UV-visible light absorbance indicated more than 90% of protein
molecules contained
a fluorescent label. These results, obtained for both
fluorescein and coumann labeling of
ACA-cys, do not meet the standards for a reviewed
publication hence they are not
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presented nor discussed in detail. However, they do provide a platform for highlighting
some exciting trends and outlining future directions for continued research.
Discussion begins with the leucine zipper molecular dynamics of an ACA system
in dilute solution as measured by FRET. Figure 5.1 shows the decay in fluorescence
intensity over time after solutions of ACA-coumarin and ACA-trp mix at time zero.
time (s)
Figure 5.1 Fluorescence decay after mixing solutions of ACA-coumarin and
ACA-trp at pH 7.0.
Under excitation at 280 nm, the tryptophan emission spectrum overlaps the
excitation spectrum of coumarin with a spectral overlap maximum at 342 nm. Thus, if
coumarin moieties maintain molecular proximity to tryptophan residues, energy transfers
from tryptophan to coumarin without emission of a photon thereby quenching tryptophan
emission maximally at 342 nm. The decay in fluorescence intensity at 342 nm over time
indicates that ACA-coumarin and ACA-trp molecules undergo a continuous folding and
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unfolding process that leads to a mixed equilibrium state. In this mixed state leucine
zipper interactions force a greater number of proximal coumarin / tryptophan pairs than
in the unmixed state. As such, Figure 5.1 provides information about the dynamics of
strand exchange and suggests leucine zippers associate in a parallel orientation. As the
focus of Chapter 5 pertains to dynamics, Appendix B outlines the reasoning that supports
parallel orientation.
Maintaining a focus on dynamics, the data in Figure 5.1 fit best to a decaying
exponential function with two characteristic decay times. Based on a tetrameric
association state of the leucine zipper, Equations 5.1 and 5.2 illustrate two possible
models that would give rise to two decay times. Note that reported values for X\ and x2
do not necessarily represent variables of like name in the following equations. Equation
5.1 follows from ultracentrifugation results reported in Chapter 4. Equation 5.2 follows
from a transition state model for dimer-forming leucine zippers
1,7
modified to describe a
tetrameric system.
M 4 <
11
> 2M 2 <
*2
> 4M (Equation5.1)
M 4 ±1±^ M * 2M 2 <-^-> 2M 2* 4M
(Equation 5.2)
If Equation 5.1 correctly describes the system, both characteristic decay times
should
vary with concentration because both describe inter-helical interactions. On the other
hand, Equation 5.2 includes inter-helical interactions, t2 and x4 , and infra-helical
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interactions, x, and x3 , which should be independent of concentration. A study that
involved mixing ACA-trp and ACA-coumarin at varying concentrations proved
inconclusive, yet weakly indicated that one characteristic decay time remains constant
while the other varies with varying protein concentration. Several scenarios could
explain how the four decay times in Equation 5.2 could reduce to two measurable decay
times; the simplest being that a specific transition (i.e. monomer to dimer) dominates the
fluorescence signal. Scenarios that are more complex take into account the fact the each
ACA molecule contains two helices thereby complicating the distinction between helical
and molecular interactions.
Even though an accurate model cannot be constructed using current data, the
measured characteristic times provide evidence for dynamic structure. Figure 5.2 shows
that pH dramatically affects dilute solution dynamics of the ACA system.
5
a
o
«
M
CD
Figure 5.2
2000
1500
1000
500 -
6.5 7.5 8.5
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9.5 10.5
Characteristic time constants, Xi (•) and x2 () for strand exchange
in the ACA system as a function of pH.
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Trends in the data suggest that as pH increases, the rate of strand exchange between
helical bundles also increases. These trends, observed in dilute solution, complement
changes in macroscopic physical properties visually observed in concentrated ACA-trp
solutions, i.e. a progression from gel to decreasingly viscous solution as pH increases.
A carefully designed and performed series of concentration and pH dependent
FRET and analytical ultracentrifugation experiments should provide enough evidence to
construct a plausible model for the solution dynamics of the tetramer forming leucine
zipper system.
Molecular dynamics can also be measure directly in gels using FRAPP. Working
from the argument that network interpenetration provides no free energy gain in the
system, dynamic strand exchange represents the only means for recovering fluorescence
within a bleached area of gel. Figure 5.3 tracks this process as measured over time by a
confocal microscope.
0.8
•
0.7
0.6
0.5 1
I(t) = A*[l-exp(-t/T
] )]
+ B*[l-exp(-t/x
2 )]
+ C
t, = 14468 s-',x2 = 237 s-
1
0.4
0 1000 2000 3000 4000 5000
time (s)
Figure 5.3 Fluorescence recovery in an ACA gel after photobleaching.
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The ill-defined sample geometry, particularly the unknown sample thickness, precludes a
meaningful analysis because fluorescence recovery occurred from all directions, the z-
direction being the most damaging. For the sake of comparison, Figure 5.3 includes a fit
of fluorescence recovery data to an exponential function with two characteristic time
constants, but these have no connection to the FRET experiments. A correct model for
FRAPP data would describe a system where strand exchange dynamics limit diffusion.
Figure 5.3 likely demonstrates two characteristic time constants because it represents a
one-dimensional analysis of a three-dimensional diffusion process.
Preliminary results in Figures 5.1, 5.2, and 5.3 demonstrate that fluorescence
techniques provide a means to explore molecular dynamics in dilute solutions and gels.
DWS provides a complementary means for exploring macroscopic physical properties of
solutions and gels. Figure 5.4 shows results from a series of DWS experiments on
concentrated ACA-trp solutions containing 800 nm PS tracer particles. The profiles
shown in Figure 5.4 demonstrate that the diffusive behavior of tracer particles within
concentrated solutions of ACA-trp depends heavily on the sample pH. Limited
instrument time prevented completion of the necessary measurements for absolute scaling
of the ordinate, thereby limiting interpretation of DWS experiments to qualitative
observations. The plateau regions of these profiles indicate local confinement of particles
over the time scale defined by the breadth of the plateau. As pH increases, particles
diffuse more freely through the system. Hypothetically, this increased mobility arises
from the increased rate of strand exchange between helical bundles at high pH, which
correlates with FRET data.
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time (s)
Figure 5.4 Mean square displacement as a function of time for 800 nm PS
probe particles in concentrated ACA-trp solutions at pH 7.3 (—),
pH -9.5 (—-), and pH 13 (••••).
D. Conclusions
Preliminary results from fluorescent and DWS experiments indicate correlations
between molecular dynamics, i.e. strand exchange between helical bundles
of leucine
zippers and macroscopic physical properties. However, a thorough
understanding of this
correlation requires a methodical series of FRET, FRAPP, and DWS experiments
systematically varying the following parameters: protein
concentration, sample pH,
sample temperature, and tracer particle size. Upon completion of
these experiments, the
array of data should suffice to propose a complete description
of the dynamic structure in
ACA-trp hydrogels.
A thorough understanding of the dynamic structure in the ACA-trp
system opens
the door to the vast field of engineered biomatenals.
Researchers could modify the
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general construct to include more specific leucine zipper domains. This would provide
fine control over certain gel properties, an ideal situation for delivery devices and
artificial ECM materials for tissue engineering. One might exchange the random coil
domain for an enzyme, drug, and/or other signaling domain(s) ideal for delivery devices,
ECMs, and biosensors. As with any successful scientific endeavor, the future holds more
promise than all the past combined.
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APPENDIX A
INTERPRETING WEIGHT- AND Z-AVERGAE MOLECULAR WEIGHTS FROM
ULTRACENTRIFUGATION
Ultracentrifugation measures variations in composition as a function of position.
Balancing equations for centrifugal force and chemical potential, the concentration of a
solute molecule, c, at a given position, r, can be written as:
dc
x _
M
l
c
i
(l-vp)co 2 r
dr ~ RT{\ + 2BM,c, + ...)
This equation is summed over all components for a polydisperse system as follows:
^X^W(l-^)XM,c,
r dr
The change in dq/dr between two distinct positions, rb and rm then becomes
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which through a series of algebraic manipulations becomes proportional to:
If data are measured by UV, the units of concentration are mol/L, or n, which yields a
weight average molecular weight when inserted into the above equation. On the other
hand, RI provides relative concentration in units of g/L, or n*M, which yields a z-average
molecular weight from the above equation.
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APPENDIX B
LEUCINE ZIPPER ORIENTATION DETERMINED BY FLUORESCENCE
RESONANCE ENRGY TRANSFER
The following figures schematically illustrate all possible orientations for ACA-
coumarin before mixing with ACA-trp.
la) 2a)
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Notice that ACA-coumarin contains both a donor (a tryptophan
residue near the
N-terminus) and an acceptor (the coumann label at the
C-terminus) for fluorescence
resonance energy transfer. If an arrow were
drawn along the protein backbone from D to
A (N-terminus to C-terminus), the arrow directions would
be as follows: 1) 2-up-2-
down, 2) 4-up, 3) 2-up-2-down, 4)
2-up-2-down. Because the random coil domain joins
two helical domains, on.y one combination, #2,
results in a parallel packing scheme.
Furthermore, this parallel orientation represents
the only state where quenching has no
chance to occur.
Now, ACA-trp only contains a tryptophan
res.due at the C-terminus, Therefore,
muting equal moles of ACA-coumann and
ACA-trp will, on average, result in the
paektng arrangements illustrated on
the following page. Notice that the
antiparalle,
onentations (1,3, and 4) all hegan with two
donor-acceptor patrs and end with one or
zero such pairs after mix.ng, i.e,
quench.ng decreases upon mixing. On the
other hand,
the parallel orientation began with
zero donor-aceeptor pairs and ends
w„h one such pair,
,e. quenchmg increases upon mix.ng.
Therefore, the observed decease in
fluorescence
intensity upon mtxing ACA-coumann
and ACA-trp ind.ca.es parallel
orientation.
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